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ABSTRACT 
 
Despite recent advances in radiotherapy, some tumours have shown to be resistant to 
treatment and patients still experience long term side effects. Gold nanoparticles (AuNPs) 
have been identified as effective radiosensitizers when employed concurrently with 
kilovoltage X-rays, which could selectively increase the dose delivered to a patient’s tumour. 
The clinical application of proton radiation has gained renewed attention due to the lower 
integral body dose of protons compared to traditional X-ray based therapy. While extensive 
research has been formed on the behaviour of AuNPs in photon beams, limited information is 
available on the combination of AuNPs and proton radiation. Several questions remain 
regarding the interaction of protons with the AuNPs and possible dose enhancement effects at 
different depths along the Spread Out Bragg Peak (SOBP).  
 In vitro radiosensitization effects of AuNPs and protons at clinically relevant energies (200 
MeV) were investigated in Chinese hamster Ovary (CHO-K1) cells by analysing its influence 
on cell growth, clonogenic survival, micronucleus induction and cell cycle progression.  The 
effects of synthesis method and size of AuNPs were investigated using Car-AuNPs 
synthesized from Elattaria Cardamom (Car) extract (green synthesis) and commercial 
AuNPs (chemical synthesis) of different sizes in CHO cells irradiated at increasing depths 
along the proton beam. 
Zeta Potential analysis, UV-vis spectroscopy and transmission electron microscopy was used 
to characterize the AuNPs.  The synthesized Car-AuNPs were stable (ZP:-19.1mV) and 
monodispersed (PDI: 0.242). The study established that intricacies in Car-AuNP synthesis 
exist and can be attuned to control Car-AuNP size and product quality. Different 
temperatures and methods of extract preparation resulted in pronounced effects on the Car-
AuNP size and dispersity level. Adjustment of these parameters yielded smaller (UV-spectral 
shifts from 590 nm to 525nm) uniformly shaped AuNPs (TEM: ~11 nm). Characterization of 
the 10 nm and 50 nm AuNPs obtained from Sigma, showed that these AuNPs were stable (-
32.8 mV and -35.1 mV) and monodispersed (PDI: 0.225 and 0.102) over a 24 hour 
incubation period at both 25 °C and 37 °C. 
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Spectrophotometrical studies and haematoxylin and eosin staining indicated that the 
chemically synthesized AuNPs stimulated mitosis at lower concentrations (5 µg/ml/ 10 
µg/ml), but exerted cytotoxic effects at high (50µg/ml) concentrations.  
Results from the clonogenic assay revealed that 50 nm AuNPs in combination with a 6 Gy 
dose of protons reduced surviving fractions of cells from 0.082 to 0.021 in the entrance 
plateau and from 0.059 to 0.013 in the middle of the SOBP.  The cytokinesis block 
micronucleus (CBMN) assay indicated an increase in the number of micronuclei (MNi) by 
the 10 nm AuNPs. In contrast, the Car-AuNPs showed a decrease in the number of MNi. This 
decrease in radiation damage could be as a result of a radioprotective effect attributable to the 
phytochemical constituents within the cardamom extract.  
Cell cycle progression showed a G1 peak (71 %) in the presence of the 10nm AuNPs in 
comparison to control G1 (33.94%) without radiation exposure.  6 Gy proton radiation caused 
an accumulation of cells in G2M, possibly indicative of a G2M block. The accumulation was 
incremental and increased with increasing depth along the proton beam, resulting in the 
largest G2M peak observed in samples irradiated in the distal position of the SOBP. 
This study verified that an interaction between AuNPs and proton radiation does exist and 
that the observed effects is dependent on the AuNP size and synthesis. Statistical analysis 
revealed that the interaction was independent of the irradiation depth along a modulated 
proton beam. However, the fact that chromosomal damage and changes in cell cycle kinetics 
were observed, warrants further investigation to clarify underlying mechanisms. 
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PREFACE 
 
Delivering a curative dose to the tumour while limiting the dose to surrounding healthy tissue 
is one of the biggest challenges in radiotherapy. The clinical application of proton radiation, 
previously maligned as a therapeutic option that is too costly, has gained renewed attention. 
This is due to the lower integral body dose of protons compared to traditional X-ray therapy 
which stems from the ability to confine the radiation dose to the malignant tissue and the lack 
of an exit dose. The reduced dose to surrounding normal tissue makes proton therapy 
particularly interesting to paediatric cancer patients, as children have a higher risk to develop 
secondary malignancies after radiation exposure.  In addition, the incorporation of proton 
therapy (PT) with nanobiotechnology presents an even greater opportunity to improve the 
efficacy of radiotherapy. 
Nanotechnology, an emerging and invasive discipline, yields particles that fall in a size range 
between 1-100 nm. Since its inception, the field has produced nanoparticles that are capable 
of accessing the minutest parts of biological systems previously known to be inaccessible by 
other particles due to the microscopic size of these systems. Thus, nanotechnology presents a 
unique option to both target and treat carcinomas individually whilst preserving the integrity 
of the surrounding healthy tissue and potentially reducing the side effects associated with 
current cancer therapeutics. 
Gold nanoparticles (AuNPs) have been extensively studied and like its bulk form, proven to 
exhibit a plethora of characteristics that can be exploited for medicinal use. AuNPs are 
selectively retained within malignant cells and have the potential to sensitize or improve the 
sensitivity of cancerous cells to radiation therapy. The combination of gold nanoparticles and 
proton radiation therefore presents an ideal mixture to enhance the effects of radiotherapy on 
radio-resistant carcinomas. 
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 CHAPTER 1: INTRODUCTION  
1. Literature Review 
1.1  Nanotechnology 
 
Nanotechnology is based on the manipulation of individual atoms and molecules to produce 
materials that fall into a scale ranging between 1-100 nm known as nanoparticles (NP) 
(Adams & Barbante, 2013). NPs exhibit unique physical and chemical properties that are 
exploited in optical, electronic, chemical and mechanical fields. Their versatility in 
nanobiotechnology stems from the ability to tailor their size, shape and composition (Arvizo, 
et al., 2010).  
The small size and high surface-to-volume ratio of NPs, allow these particles easy access to 
biological systems and molecules (Blecher, et al., 2011) consequently gaining a foothold in 
the medical field (Miu & Sprando, 2010). A multitude of nanoparticles have been created 
with the main goal of enhancing the properties of a system previously stagnated by a lack of 
advancement in technology.   
 
 
 
 
 
 
 
 
 
NPs can be deployed for the transport and delivery of a variety of biomedical entities for the 
treatment, prevention and diagnosis of many diseases (Figure 1.1) (Datta & Jaitawat, 2006; 
Sanna, et al., 2014; Pandey & Ahmad, 2011). The ability to effect diagnostic and therapeutic 
changes on a nanoscale could provide significant changes in medical care (Gannon, et al., 
2008). 
Figure 1.1: Example of the host of biomedical applications offered by NPs. Excerpted from Sanna 
et al., 2014 
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More recently, the breakthrough potential of cancer nanotechnology has been exhibited by 
various research papers employing NPs to improve cancer therapy (Bertrand, et al., 2014). 
1.1.2 The need for novel therapies in cancer treatment 
 
Despite the development of targeted chemotherapeutic drugs over the past 20 years, cancer 
remains among the deadliest of human diseases (Linton, et al., 2016).  
At present, intrusive processes such as chemotherapy, radiation and surgery to remove the 
tumour if possible, potentially followed by more chemotherapy and radiation, form the most 
successful cancer treatments (Yao, et al., 2016). However, anticancer agents do not 
differentiate between malignant and normal cells, leading to severe systemic toxicities 
(Sinha, et al., 2009). Therefore, the benefits of the treatments are often marred by the 
negative side effects and a high percentage of tumour recurrence (Foote, et al., 2012; Curren, 
et al., 2011). 
NPs hold the potential to address and remedy some of the most significant limitations of 
chemotherapy, namely, its lack of specificity and narrow window of therapeutic efficacy 
(Steichen, et al., 2013). AuNPs are one of the most widely studied metallic NPs for their 
potential application in cancer diagnostics and treatment (Mirkin, et al., 2010). NPs are 
particularly relevant to tumours because tumours possess a leaky vasculature that is absent in 
normal/healthy tissue. Upon intravenous administration, NPs tend to circulate for longer 
times, if they are not small enough for renal excretion or large enough for rapid entrapment 
and recognition by the reticuloendothelial system (Yin, et al., 2014; Kobayashi, et al., 2014). 
AuNPs (without surface modification), will thus preferentially leak into tumour tissue via the 
leaky vasculature and are then retained in the tumour bed due to reduced lymphatic drainage. 
This process is known as the enhanced retention and permeability effect (EPR) (Kobayashi, 
et al., 2014).  Auroshell is a gold nanoshell that uses passive targeting to reach tumour cells 
and is currently being applied in a clinical trial. Once inside, near- infrared laser light is 
applied, which heats the particles and thermally destroys the tumour and surrounding blood 
vessels without significant damage to healthy tissue (Grossman & Mc Neil, 2012). Thus 
AuNPs present the potential for a variety of applications and have been incorporated into 
various forms of therapy to improve its efficacy. 
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1.2 Gold Nanoparticles (AuNPs) development 
 
Gold has been highly regarded as a medicinal compound for centuries (Jemal, et al., 2009). 
The first information on colloidal gold is recorded in treatises by Arabian, Chinese and Indian 
scientists who tried to attain colloidal gold as early as the fourth-fifth centuries (Daraee, et al., 
2014). The discovery of AuNPs have been attributed to Michael Faraday’s observation over 
150 years ago, that colloidal gold solutions have properties that differ from its bulk 
counterpart (Hayat, 1989; Mirkin, et al., 2010). Years later, gold was incorporated into 
clinical trials initiated in 1925 to determine the efficacy of gold complexes in alleviating 
rheumatoid arthritis (Aaseth, et al., 1998). Recently, AuNPs have become a central 
component of medical discovery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Photographic evidence of the presence of AuNPs in human products for centuries A) 
Egyptian gold plated archaeological ivory B) 4th century Roman Lycurgus cup which appears red upon 
illumination from the front and green upon illumination from the back C) Teapot (1680) obtained by 
Johannes Kunkel using the ‘ Purple Casius’ technique D) Michael Farady’s original gold colloid 
samples. Image generated by and excerpted from (Vincenzo, et al., 2017).  
 
 
Figure 1. 22Figure 1.23: Photographic evidence of the presence of AuNPs in human products 
for centuries A) Egyptian gold plated archaeological ivory B) 4th century Roman Lycurgus cup 
which appears red upon illumination from the front and green upon illumination from the back 
C) Teapot (1680) obtained by Johannes Kunkel using the ‘ Purple Casius’ technique D) 
Michael Farady’s original gold colloid samples. Image generated by and excerpted from 
(Vincenzo, et al., 2017).  
 
 
Figure 1.2: Photographic evidence of the presence of AuNPs in human products for centuries 
A) Egyptian gold plated archaeological ivory B) 4th century Roman Lycurgus cup which 
appears red upon illumination from the front and green upon illumination from the back C) 
Teapot (1680) obtained by Johannes Kunkel using the ‘ Purple Casius’ technique D) Michael 
Farady’s original gold colloid samples. Image generated by and excerpted from (Vincenzo, et 
al., 2017).  
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1.2.1 AuNPs and their application in medicine 
 
Characteristic surface plasmon resonance (SPR) exhibited by AuNPs, results from photon 
confinement to a small particle size, enhancing all the radiative and non-radiative properties 
of the AuNPs offering multiple modalities (Huang & El-Sayed, 2010). AuNPs also have 
versatile surface chemistries which permits them to be coated with a wide range of 
molecules, allowing for diverse applications (Klebstov & Dykamn, 2010). 
The unique optical properties of AuNPs, and the nearly 100 % conversion of absorbed light 
to heat, is sufficient to induce cellular damage such as hyperthermia, coagulation and 
evaporation (Svaarsand, et al., 1990; Dorsey, et al., 2013). Additionally, the high atomic 
number of gold allows elevated absorption and enhancement of ionizing radiation, such as 
superior X-ray attenuation for imaging applications (Dorsey, et al., 2013). 
 
 
 
 
 
 
 
Figure 1.3: AuNPs are versatile and tuneable to various shapes and sizes, can be functionalized are 
generally safe and non-toxic and in vitro and in vivo. They have the ability to enhance radiation and 
serve as excellent contrast agents (Dorsey, et al., 2013). 
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1.3 AuNP synthesis   
 
Several approaches exist for the fabrication of AuNPs; the crudest method, reduction of gold 
during which gold salts are reduced, was created by Turkevich in 1951 (Turkevich, et al., 
1951)  and modified by Frens (Frens , 1972). During this process, the nucleation of gold ions 
results in the formation of AuNPs (Arvizo, et al., 2010). The technique is based on the 
reaction that occurs for all bottom-up AuNP synthesis procedures in which an auric 
compound/metal salt (usually tetrahydrochloroauric acid (HAuCl4 3H2O)) is reduced by a 
chemical (citrate) reducing agent to yield the non-oxidized state of gold (Au [I]) thus forming 
AuNPs. Changing various parameters within the synthesis process can yield AuNPs of 
different sizes, shapes and stability (Tran, et al., 2016). 
AuNPs can also be produced via the Bruscht-Schiffrin method. Devised in 1994, the authors 
developed the method to create AuNPs in organic liquids that are usually immiscible in water 
(Brust, et al., 1994). Like the Turkevich method, the reaction involves the reduction of 
chloroauric acid ions to form AuNPs. In addition to the aforementioned methods, a multitude 
of AuNP synthesis methods exists that are exploited by privately owned scientific companies 
to create stable, monodisperse AuNPs available commercially for research purposes.  
Figure 1.4: Schematic of therapeutic applications of AuNPs. Image excerpted from (Yao, et al., 
2016)  
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However, chemical methods for synthesizing metal NPs generally use expensive and toxic 
reagents as reducing and stabilizing agents, and it is likely that trace amounts of  reagents 
remain unreacted in solution posing danger to the environment (Shankar, et al., 2004).To this 
effect, one of the most essential needs in nanotechnology is to develop environmentally 
friendly and ‘green’ approaches to nanoparticle synthesis and has resulted in the inception of 
green chemistry (Thakkar, et al., 2010).  
 
1.3.1 Green Chemistry and AuNPs 
 
Green synthesis of NPs (Green-NPs) can be realized without toxic and aggressive chemicals 
(Li et al., 2009) as it requires a biological compound as a reducing reagent. Green synthesis is 
cost effective and can be manipulated to give rise to a variety of shapes and sizes. Since 
biological molecules are used for the synthesis, the resulting AuNPs are capable of evading 
immune detection, have improved stability as well as tumour-targeting characteristics 
(Shukla, et al., 2005). The phytochemicals and bioactive substances such as flavonoids, 
phenols, terpenes and alkaloids in various plants, act as reducing agents and environmentally 
benign reservoirs for the production of NPs (Nune , et al., 2009).   
 
Plant-mediated NP synthesis has thus become a very promising area in nanotechnology 
because the plant itself acts as both a reducing and capping agent (Figure 1.4) it has been 
Figure 1.5: reactions involved in the green synthesis of gold nanoparticles and their applications 
(Santhoskumar, et al., 2011). 
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shown that plants infer medicinal properties onto AuNPs during the synthesis procedures 
(Santhoskumar, et al., 2011; Lal & Nayak, 2012; Geetha, et al., 2013).  
Abel-Raouf et al, successfully produced stable Green-AuNPs from Galaxuara elongate (G. 
elongate), an algal extract or powder. G. elongata, known to exhibit bactericidal activity, 
only proved effective against Methicillin  Resistant Staphylococcus Aureus (MRSA), whereas 
its AuNP product inhibited the growth of Escherichia coli (E.coli), Klebsiella pneumoniae 
and MRSA respectively (Abdel-Raouf, et al., 2017).  
Green-AuNPs have also been successfully synthesized from spices. The phytochemicals 
present in spices inhibit carcinogenesis through their bioactive components which block the 
activity of cytochrome P450, cyclooxegenase-2 (COX-2) and downregulate signal 
transducers (Bhagat & Charturvedi, 2016).  Cinnamon phytochemical reservoirs have been 
used to coat AuNPs. These AuNPs showed no cytotoxicity, but displayed high uptake in 
cancerous cells in vitro and in vivo and facilitated detectable photoacoustic signals revealing 
the potential application of the phytochemical coated AuNPs as an excellent photoacoustic 
contrast agent (Chanda, et al., 2011).  
1.3.2  Cardamom 
 
Cardamom is a commonly used spice in Indian and Asian cuisines (Mueller, et al., 
2010).Two major forms of cardamom generally exists. “Green or true caradamom” (Elattaria 
cardamomum) (Figure 1.6) and “Black or Brown” cardamom (Amomum subulatum).  It has 
also been applied as a naturopathic agent against digestive disorders, the common cold, 
pulmonary tuberculosis as well as gum and throat infections (Sharma, et al., 2011). The large 
application of cardamom homoeopathically, has led to researchers investigating the in vitro 
and in vivo effects of cardamom on various disease pathologies. 
The in vitro efficacy of cardamom was studied by researchers that encapsulated cardamom 
essential oil into chitosan NPs. As an antimicrobial agent, the cardamom loaded NPs 
exhibited excellent potential against extended β lactamase producing E.coli and MRSA. 
Cytotoxicity analysis indicated non-haemolytic and non-cytotoxic behaviour on human 
corneal epithelial cells and Human Hepatocellular Carcinoma (HepG2) cell lines (Jamil, et 
al., 2016). It has also been shown that cardamom ingested as a dietary phytoproduct, displays 
strong activity against 7,12-Dimethylbenz[a]anthracene (DMBA)-induced skin 
papillomatogenesis in Swiss Albino mice. The DMBA treated mice experienced blocked 
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Nuclear Factor Kappa Beta (NFK-B) activation and down regulated cyclo-oxygenase-2 
(COX-2) expression resulting in reduction in both the size and number of skin papillomas 
(Das, et al., 2012). In addition, cardamom is a powerful anti-inflammatory and has been 
shown to downregulate cytokines such as COX-2, Interleukin-6 (IL-6), Tumour Necrosis 
Factor-alpha (TNF-α) and inhibited inducible nitric oxide synthase (iNOS) mediated Nitric 
Oxide (NO) generation (Kandikattua, et al., 2017). 
 
 
 
 
 
 
 
Research by Rajan et al revealed that cardamom synthesized AuNPs (Car-AuNPs) exhibit 
antibacterial activity against a broad spectrum of bacterial pathogens and that this activity 
was enhanced against E.coli, Staphylococcus aureus (S.aureus) and Pseudomonas 
aeruginosa. The Car-AuNPs also showed cytotoxicity towards Hela cancer cell lines (Rajan, 
et al., 2017).  
Cardamom extract was also successfully used to synthesize silver nanoparticles (AgNPs).  
The authors showed that Car-AgNPs successfully inhibited the growth of S. aureus and 
E.coli. Car-AgNPs displayed potential as a cytotoxic agent against breast cancer, whilst both 
types of NPs were effective radical scavengers (Soshnikova, et al., 2017). A study by Singh 
and Srivastava that used black cardamom, proved that changes in salt concentration ratio as 
well pH influenced the characteristics of AuNPs. HAuCl4 quantity clearly affected AuNP size 
whereas the pH adjustments affected AuNP morphology. Additionally, the study established 
1.8-cineole as the bioactive compound responsible for driving the synthesis of Au3+ to Au0 
(Singh & Srivastava, 2015). 
The volatile oil of cardamom is made up of a large number of monoterpenes (97.5%). The 
monoterpene make-up as characterized by Ali and Husain, consists of seven monoterpene 
hydrocarbons (9%), three monoterpene esters (1.3%), and seven monoterpene alcohols 
Figure 1.6:  Elattaria cardamomum commonly known as “Green or true cardamom” represented 
photographically. Image retrieved from ayurveda.alandiashram.com 
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(86.7%), of which the predominant monoterpene is 1.8 cineole ( 85.2%) followed by α-
terpinene (2.2%).  During the research group’s phytochemical investigation, it was 
discovered that many components of cardamom are highly bioactive and thus required 
investigations into the chemical and biological composition (Ali & Husain, 2014). 
1.4 Radiation Therapy 
 
Over 50 % of patients with malignant tumours receive radiation therapy (RT) as part of their 
initial therapy, either alone or in combination with surgery and chemotherapy, which makes it 
an essential tool for curing cancer (Loeffler & Durante, 2013). RT is based on the deposition 
of energy along the path of incident radiation. In the initial (physical) radiation stage 
photons/ions interact with the cell, resulting in either direct damage to the deoxyribonucleic 
acid (DNA) or indirect damage through the generation of secondary low energy electrons, or 
radicals that can act as intermediaries and damage the DNA (Haume, et al., 2016).  
 
 
 
Radiation induced DNA strand breaks are integral role players to the fate of the cell leading 
to cell death or mutagenesis depending on the damage quality and the cell repair ability 
(Frances, et al., 2010; Taggart, et al., 2014). Radiation can induce a variety of lesions in the 
DNA: single strand breaks (SSB), double-strand breaks (DSB) formed by two SSB separated 
by less than ten base pairs distance limit and clustered strand breaks where more than two 
impairments are located within the mentioned distance limit respectively, on one and two 
strands (CSB and  CSSB respectively) (Francis, et al., 2011).  
Figure 1.7 Illustration of mechanisms of radiation damage. Photon radiation (red wave-like line and 
straight line) may directly damage the DNA (yellow stars) or indirectly damage DNA as well as 
other cellular components (mitochondria) (Haume, et al., 2016) 
 
 
Figure 1.42: Energy deposition vs depth. The total energy delivered is proportional to the 
area under the red “protons” curve, The SOBP (Spread Out Bragg Peak) is formed by a 
suitable superposition of many different mono-energetic proton beams indicated by the blue 
line.Figure 1.43 Illustration of mechanisms of radiation damage. Photon radiation (red 
wave-like line and straight line) may directly damage the DNA (yellow stars) or indirectly 
damage DNA as well as other cellular components (mitochondria) (Haume, et al., 2016) 
 
 
 
Figure 1.9: a) Energy deposition vs depth. The total energy delivered is proportional to the area 
under the red “protons” curve, The SOBP (Spread Out Bragg Peak) is formed by a suitable 
superposition of many different mono-energetic proton beams indicated by the blue line.Figure 1.7 
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X- or gamma-rays (photons) are sparsely ionizing and known as low linear energy transfer 
(LET) radiation. Most of the DNA damage caused by low LET radiation is repairable (Porcel, 
et al., 2010). LET measures the density of ionization events per unit length along radiation 
tracks. Densely ionizing (high LET)  radiation deposits enough energy to inactivate a cell in 
one single track, whereas sparsely ionizing radiation (low LET) requires several tracks, each 
depositing a small amount of energy insufficient to kill a cell, to achieve the same effect 
(Scalliete & Gueulette, 2017). An adequate dose of ionizing radiation can kill a tumour cell, 
but the concerns of the amount of damage to healthy tissue residing in the environment 
surrounding the tumour, limit how much radiation a patient can receive (Porcel, et al., 2014). 
Figure 1.8 Schematic representation of the difference in radiation tracks. For low-LET radiation, the 
inactivation of a radiosensitive target requires the conjunction of several tracks, whereas for high-LET 
radiation the impact of a single track is always fatal (Scalliete & Gueulette, 2017). 
Cancer tissues can have, or develop, a resistance to photon radiation; and in addition, due to 
the physical position of the lesion, it can be difficult to effectively irradiate the tumour 
completely, leading to its regeneration (Kwatra, et al., 2013). Developments in RT such as 
particle therapy (proton and carbon ion therapy) are aimed at reducing the amount of normal 
tissue that is co-irradiated. However, particle therapy is more expensive than conventional 
therapy and therefore limited to the localized tumours in proximity to critical organs or 
tumours resistant to conventional treatments. 
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1.4.1 Proton Therapy (PT) 
 
Protons (Hydrogen ions) are positively charged subatomic particles. They possess a unique 
depth-dose interaction with matter providing dosimetric advantages over X-ray therapy 
(Mohan, et al., 2013). The clinical rationale for PT is motivated primarily by their inverted 
depth-dose profile compared to photons. While the depth-dose curve of photons is 
characterized by a decrease in energy deposition with increasing depth after a short build-up, 
protons deposit a relatively low dose in the entrance channel (plateau) followed by a steep 
increase and sharp dose fall-off towards the end of their range in the so-called Bragg peak, 
beyond which no radiation dose is deposited (Fig 1.9). This allows the positioning of the 
region of maximal energy within the treatment target, while damage to surrounding healthy 
tissue organs and tissues is limited (Foote, et al., 2012; Newhauser & Zhang, 2015; Girdhani, 
et al., 2013; Kim, et al., 2010).   
In theory, it also allows higher doses to be administered, potentially reducing the recurrence 
rate without increasing the complication rate and leading to better organ function and quality 
of life (Foote, et al., 2012). The effective targeting of PT, combined with the reduced dose in 
healthy tissue (Figure 1.9 b), is particularly important in the treatment of paediatric cancers in 
light of the fact that the risk of developing late morbidity or secondary cancers is so much 
greater in young patients (Mohan, et al., 2013).    
Theoretically, the Bragg Peak allows the beam to be pointed directly to a critical structure, 
increasing the flexibility of PT treatment planning compared to normal photon therapy 
(Paganetti, 2012). Additionally, the Bragg Peak can be modulated to cover the entire tumour 
volume. Herein, several proton beams of different energies are combined to achieve the 
required depth-dose distribution necessary to cover the target volume. This produces a flat 
region along the Bragg Peak known as the Spread Out Bragg Peak (SOBP) (Figure 1.9) 
(Britten, et al., 2013; Tommasino & Durante, 2015).  The rapid distal drop in dose at the end 
of the SOBP, is ideal in the treatment of tumours located in close proximity to organs at risk, 
further compounding the benefits of PT (Marshall, et al., 2016).  
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1.4.2 Relative Biological Effectiveness (RBE) and Proton Therapy 
 
Comparison between the biological effects of different types of radiation are usually 
expressed as Relative Biological Effectiveness (RBE). RBE is the ratio of the dose of photon 
radiation to the dose of a reference radiation that produces the same biological effect. 
However, the RBE can also be measured within the Bragg Peak region compared to the 
incident plateau region of an ion energy loss distribution. Protons are known to show a 
slightly increased RBE when compared to photon radiation and an RBE of 1.1 is currently 
accounted for in clinical practice compared to 1 for photons (Grün, et al., 2017). However, in 
the last part of the SOBP, the average proton energy decreases rapidly, leading to an 
increased linear energy transfer (LET).Paganetti et al, (2002) states that the particle type and 
the underlying dose averaged linear energy transfer (LETd), cell type, biological endpoint and 
dose level are the main variables to consider in RBE. Values as high as 1.6 in the distal 
region of the plateau of the SOBP and as high as 2.9 in the distal fall-off being reported by 
several authors, question the validity of a general RBE of 1.1 for protons in clinical practice 
(Britten, et al., 2013).  
Figure 1.9: a) Energy deposition vs depth. The total energy delivered is proportional to the area 
under the red “protons” curve, The SOBP (Spread Out Bragg Peak) is formed by a suitable 
superposition of many different mono-energetic proton beams indicated by the blue line. A 
megavoltage photon beam depth-dosage profile indicated by the green line shows that at target 
dose depths (10-15cm) the energy is the same as the SOBP. Near the entry point however, photons 
deposit substantially more energy outside the target depth (Girdhani, et al., 2013). Image excerpted 
from (Mohan, et al., 2013) b) Colour shaded CT scan depicting the difference in irradiation dose 
deposition with proton compared to photon irradiation.  
 
 
Figure 1.9: a) Energy deposition vs depth. The total energy delivered is proportional to the area 
under the red “protons” curve, The SOBP (Spread Out Bragg Peak) is formed by a suitable 
sup rposition of many different mono-en rgetic proton beams indicated by the blue line. A 
megavoltage photon beam depth-dosage profile indicated by the green line shows that at target 
dose depths (10-15cm) the energy is the same as the SOBP. Near the entry point however, photons 
deposit substantially more energy outside the target depth (Girdhani, et al., 2013). Image 
excerpted from (Mohan, et al., 2013) b) Colour shaded CT scan depicting the difference in 
irradiation dose deposition with proton compared to photon irradiation.  
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Generally, RBE is considered to increase with increasing LET, whereas it decreases with 
increasing dose (Villagrasa, et al., 2014). Although protons are generally viewed as low LET, 
the radiation quality of such proton beams have a high LET component towards the end of 
their range which could result in an increased complexity of DNA damage, with a possible 
corresponding decrease in repair efficiency and rise in the number of biologically important 
unrepaired breaks (Marshall, et al., 2016). 
1.5 The use of gold nanoparticles as agents for radiosensitization 
 
The main goal of RT is the delivery of a lethal dose of radiation to a tumour whilst 
simultaneously sparing surrounding healthy tissue. Great effort has recently been 
concentrated on the attainment of this goal and has resulted in two distinct categories, the 
first, conforming the delivered dose to the tumour volume and second, enhancing the 
sensitivity of the tumour to therapeutic radiation (Polf, et al., 2011). Radiosensitizing 
adjuvants that enhance the dose specifically absorbed by tumour tissue can result in enhanced 
tumour killing for any given total radiation dose compared to radiation therapy alone 
(Dorsey, et al., 2013). Recently, a combination of radiotherapy and NPs have been proposed 
as a new alternative to improve current treatment protocols (Porcel, et al., 2010).  
In a review by Retif et al, a clear trend amongst radio-enhancement based studies is defined. 
High atomic number (Z=79) nanoparticles, in the context of radiosensitization, have been 
found to intensify the production of secondary electrons and reactive oxygen species (ROS) 
that in turn enhances radiation therapy effects (Retif, et al., 2015). It is thought that the 
overall treatment dose could be reduced, by increasing the local dose to the tumour through 
the use of NPs and as a consequence, decreasing side effects (Jeynes, et al., 2014). AuNPs in 
particular, signify a biologically compatible and safe class of materials that has attracted 
considerable attention in cancer therapy and imaging (Zhang, et al., 2008), and has been 
successfully implemented in studies striving to exhibit AuNPs’ efficacy as a radiosensitizing 
agent. 
Zhang et al, (2008) used thiol-glucose or sodium citrate capped AuNPs were used to explore 
the difference in uptake of AuNPs and the subsequent interaction of AuNPs with radiation in 
prostate carcinoma cells. The research team was able to successfully exhibit cell selectivity 
for AuNPs capped with thiol-glucose showing a three-fold increase in uptake of these when 
compared to their counterpart. Furthermore, using an X-ray machine at 220 kVp, a 2Gy dose 
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was delivered to the cells and a 45.97% inhibition of cell growth was seen in cells exposed to 
both X-rays and AuNPs. These findings, though valid, also exhibit the progression of the 
knowledge surrounding AuNP based radioenhancement studies since. Zhang et al, remarked 
that AuNPs less than 50 nm traverse the cell membrane more efficiently than larger AuNPs 
and that those below 20 nm effectively gain entry to the cell nucleus. However, the contrary 
has since been proven by Chitrani et al, 2010. 
An in vitro study by Chitrani and collaborators in 2010, investigated radiosensitization by 
AuNPs as a function of AuNP size, using low energy X-rays. The research group exposed 
HeLa cells to AuNPs of varying sizes (14 nm, 74 nm and 50 nm) and showed that the greatest 
level of cellular uptake and radiosensitization was exhibited by the 50 nm AuNPs (Chitrani, 
et al., 2010).  
1.5.1 The underlying mechanism of radiosensitization 
 
The Compton and Photoelectric effect are the main physical mechanisms underlying the 
interaction between keV X-ray beams and metallic NPs. An incident photon is either partially 
or fully absorbed by the nanoparticle resulting in the ejection of an electron from the NP 
surface (Mc Mahon, et al., 2016). Ionizing radiation has enough kinetic energy to detach at 
least one electron from an atom, NP or molecule, creating ions. Charged particles such as 
electrons, protons, heavy ions, alpha and beta particles are directly ionizing because they can 
interact directly with atomic electrons through Coulomb forces and transfer a major part of 
their kinetic energy directly.  
In contrast, photons (X-rays or γ-rays) and neutrons are not charged and therefore more 
penetrating. They are indirectly ionizing, and have sufficient kinetic energy to free an orbital 
electron producing a ‘fast’ recoil or Compton electron that is, in turn directly ionizing. Strong 
photoelectric absorptions lead to dramatic increases in absorbed dose (Butterworth, et al., 
2013). Auger electrons or fluorescent photons are produced by energy released from electrons 
that drop from higher orbits when replacing ejected electrons. Auger electrons have a much 
shorter range of coverage but can generate a much higher ionization density at a localized 
area. Consequently, Auger electrons deposit their energy within the vicinity of the AuNP, 
which leads to high inhomogenous dose distributions on the nanoscale. Thus it can be 
anticipated that the combination of radiation with the AuNPs would lead to an enhancement 
in radiosensitization (Saberi, et al., 2017).  
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Figure 1.10:  Schematic depicting electron ejections upon X-ray interaction with high-Z 
materials (Saberi, et al., 2017). 
 
 
 
 
 
 
 
 
 
 
 
1.5.2 Proton radiation and gold nanoparticles 
 
Though AuNPs have been successfully implemented in studies as potential radiosensitizers, 
most of the current studies are limited to relatively low-energy kilovoltage X-rays. Only a 
few reports have been carried out with relatively high energy particles that have been used to 
irradiate cells or tumours containing nanoparticles showing radiosentization similar to those 
found in X-rays (Kim, et al., 2010; Jeynes, et al., 2014). Most of the studies show or predict a 
less pronounced dose enhancement effect with clinical protons compared to low- energy X-
rays (Jeynes, et al., 2014). However, kV X-rays have a limited use clinically due to their 
shallow penetration depth in the patient. From that perspective, protons are a promising 
candidate for radiosensitization with AuNPs, since the cross-section of high-Z materials to 
protons is large at clinically relevant energies (>60 MeV). Furthermore, the slightest dose 
enhancement effect could already impact therapeutic efficacy. 
Theoretical work by Verkhovtsev et al showed that metal NPs (MNPs) with ion therapy 
significantly increased the secondary electron yield when compared to that of pure water, due 
to the excitation of plasmons in the nanoparticle. More specifically, noble metal nanoparticles 
were shown to be superior to other (e.g gandolinium) NPs (Verkhovtsev, et al., 2015a; 
Verkhovtsev, et al., 2015b). 
A lack of experimental studies investigating proton and AuNP interaction in cells has caused 
very little validation of previous theoretical simulation findings. However, Kim and co-
authors have explored the interaction of various metal nanoparticles and proton radiation and 
their biological effect. Their research has mainly been centred on particle–induced X-ray 
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emission (PIXE) or particle-induced gamma ray emission (PIGE) in which it is described that 
MNPs are activated by high energy particles such as protons and upon activation, release X-
rays or gamma-rays (Kim, et al., 2010). 
In 2009, Kim et al demonstrated that the tumour cytotoxicity of a 45 MeV proton beam was 
enhanced up to 20-28% by PIXE effects in a proton dose-dependent manner when coupled 
with administered superparamagnetic NPs. Furthermore, the research group investigated the 
PIXE effects caused by the interaction between a 2.4 MeV beam and AuNPs, ligand coated 
AuNPs (L@AuNPs) or Iron NPs (FeNPs) and the bearing this has on tumour cytotoxicity. 
Both the in vivo and in vitro study showed increased PIXE effects as NP concentrations were 
increased in vitro. Furthermore, when coupled with a 45 MeV SOBP proton beam, higher 
concentrations of NP treatment displayed decreased cell survival fractions. Using a tumour 
regression assay, the obtained in vivo results demonstrated significant dose enhancement 
thought to be due to PIXE effects when compared to conventional proton therapy without 
NPs (Kim, et al., 2010). 
According to Otani, et al, the outcome of irradiation is affected by the cell cycle. Thus the 
biological changes in cell cycle progression in response to insult also requires investigation in 
order to illuminate effects seen in response to treatment (Otani, et al., 2016). 
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1.6 Overview of the Cell cycle and DNA damage repair processes 
  
The cell cycle comprises four phases in which G0 is seen as a resting period just prior to the 
first phase, Gap phase-1 (G1). The internal cell cycle signalling system takes over from 
growth factor (GF) signalling and controls the events of the S-phase, Gap phase 2 (G2) and 
mitosis (M-phase) (Barnum & O'Connell, 2014). Cell cycle progression is subject to control 
mechanisms.  
Key regulators of the cell cycle are proteins called cyclins that bind to cyclin dependent 
kinases before the kinases can become enzymatically active. (Malumbres & Barbacid, 2009).  
 
 
 
 
 
 
 
 
 
 
 
D-type cyclins (D1, D2, and D3) are key regulators of G1 progression and formation of active 
complexes between D-type cyclins and CDK4/CDK6 is subject to regulation by extracellular 
signals. Cyclin E, in association with CDK2, is required for the G1/S transition and cyclin A 
in a complex with CDK2, is essential for progression through S phase. Lastly, both cyclin A 
and the B-type cyclins associate with CDK1 to promote entry into mitosis. The mechanisms 
of CDK regulation consist of positive regulation by cyclin abundance, phosphorylation by 
CAK (cyclinH/CDK7) and dephosphorylation by phosphatases (members of the Cdc25 
family) as well as negative regulation by inhibitory tyrosine phosphorylation through Wee1 
and Mik1 (Barnum & O'Connell, 2014). Other controls, termed checkpoint controls, originate 
Figure 1.11: Diagram depicting the phases of the cell cycle. Image obtained from (Biosciences, 
2014) 
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from within the cell and arise from the need to coordinate different cell cycle events, and to 
halt cell cycle progression in response to irregularities such as DNA damage or faulty spindle 
assembly (Guo & Hay, 1999). 
 
1.6.1  Gap phase 1  
 
The G1 phase ensures that the cell is ready to enter the S-phase based on nutrient and growth 
factor availability (Budirahardja & Gönczy, 2009).Central to its functionality is the activation 
and inactivation of nuclear phosphoprotein Retinoblastoma (RB). Phosphorylation of RB by 
CDK 4/6 and cyclin D complex results in the release of the E2F transcription factor (Morgan, 
et al., 1998) inducing the transcription of genes necessary for the G1/S transition and S-Phase 
(Deckbar et al., 2011; Dubrovnik & Scott., 2000). 
 
1.6.2 The S-phase  
 
The replication of DNA begins with the ordered assembly of a multiprotein complex called 
the pre-replicative complex (pre-RC). Assembled prior to the S-phase at origins on DNA, 
pre-RCs initiate replication by promoting origin unwinding and facilitating recruitment of 
DNA polymerase (Takeda & Dutta, 2005).  The formation of pre-RCs occurs when a 
multiprotein complex known as the origin recognition complex (ORC), binds the origins on 
DNA and serve as landing pads for several additional regulatory proteins (O'Connor & 
Adams, 2010). There are 6 ORCs which are located among six chromosomes. ORC recruits 
the initiation factors (regulatory proteins) Cdc6 and Cdt1 to origins, which are both in turn 
responsible for loading the minichromosome maintenance (Mcm2-7) complex.  Replication is 
initiated upon Mcm loading. Pre-RC formation occurs during both early G1 and late M 
phases licensing the DNA for replication during the S-phase (Takeda & Dutta, 2005). 
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1.6.3 The G2M phase 
 
The second gap phase is another growth phase in which cells prepare to enter mitosis. Mitotic 
entrance is dependent on the cyclinB/CDK1 complex, activated by phosphorylation by CAK 
on threonine 161. Hyperphosphorylation of CDK1 on tyrosine 15 and threonine 14 through 
Wee1 and Myt1 kinases results in a temporary block during which the replicated DNA is 
checked. Central to this phase of the cell cycle is the (cell cycle division 25) Cdc25 
phosphatase family. The inhibitory kinases are removed by Cdc25B and Cdc25C, activating 
the cyclinB/CDK1 complex (Cappelletti, et al., 2000). Cdc25A generally plays a role in cell 
cycle transition particularly at the G1/S transition and the exit of mitosis (Donzelli & Draetta, 
2003). When cyclin B-CDK1 is activated it phosphorylates substrates required for 
chromosome condensation, nuclear envelope breakdown and formation of the mitotic spindle. 
On completion of mitosis, cyclin B is degraded via the ubiquitin-proteasome pathway, 
leading to the dissociation and inactivation of the complex and mitotic exit. 
1.6.4.   Restriction Points 
 
Restriction points are seen as critical regulatory mechanisms allowing a cell to monitor its 
environment and size. This makes them an integrator and fundamental decision maker 
controlling the switch between alternative cellular fates such as cell division, temporal cell 
cycle arrest, quiescence and differentiation (Bartek, et al., 1996). According to the cell cycle 
stages, DNA damage checkpoints are classified into at least 3 checkpoints: The G1/S (G1) 
checkpoint, the intra-S phase checkpoint, and the G2/M checkpoint (Murray, 1994). There are 
more checkpoints such as the spindle checkpoint and morphogenesis checkpoint. The spindle 
checkpoint arrests the cell cycle at the M phase until all chromosomes are aligned on the 
spindle (Murray, 1994). This checkpoint is very important for equal distribution of 
chromosomes. The morphogenesis checkpoint detects abnormality in the cytoskeleton and 
arrests the cell cycle at G2/M transition (Blagosklonny & Pardee, 2002). 
 
1.6.4.1.   The G1/S checkpoint 
  
The G1/S arrest due to DNA damage causes a delay in cell cycle progression to facilitate 
DNA repair, thus preventing mutations. Entrance into S-phase is regulated by either a p53 
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dependent or p53 independent pathway (Clémenson & Marsolier-Kergoat, 2009). The p53 
independent pathway is known as Cdc25A pathway. These pathways share the same key 
upstream regulators, ataxia-telangiectasia mutated/ATM and Rad3-related (ATM/ATR) and 
checkpoint kinases 1 and 2 (Chk1/Chk2) and target Cdc25A, a dual specificity phosphatase 
and p53 simultaneously within minutes after DNA damage. ATM is mainly activated in 
response to DSBs, whilst ATR is primarily activated following replicative errors that result in 
single-stranded DNA (Clémenson & Marsolier-Kergoat, 2009). 
Chk2 phosphorylates the Cdc25A phosphatase in several serine residues, which stimulates 
ubiquitination and proteasome mediated degradation of Cdc25A leading to cell cycle arrest 
(Zhou & Elledge, 2000). Degradation of Cdc25A inhibits CDK2 activity thus preventing 
recruitment of DNA polymerase α and initiation of DNA synthesis (Stracker, et al., 2009). 
ATM is also responsible for the activation of tumour suppressor protein p53 (G1/S arrest 
maintenance). The activation of p21 by p53 regulates the transition between G1 and S-phase 
by interacting with CDK2, repressing the kinase activity of cyclinD-CDK4, cyclinE-CDK2, 
and cyclinA-CDK2. The inhibition of both the cyclin-CDK complexes leads to the 
dephosphorylation of RB which therefore cause the inhibition of the E2F dependent 
transcription of S phase genes and more importantly, DNA damage repair (Zhou & Elledge, 
2000).  
 
1.6.4.2.   G2M checkpoint 
 
The biochemical pathways involved in the DNA damage induced G2 checkpoints are 
signalling cascades that unite to inhibit the activation of CDK1. This checkpoint is very 
similar to the G1/S checkpoint. DNA double-strand breaks activate the ATM-Chk2-Cdc25 
pathway and DNA lesions such as UV light activate the ATR-Chk1-Cdc25 pathway. Down 
regulation of Cdc25A, Chk1, Chk2 and Wee1 regulates CDK1 activity and consequently G2 
arrest together with p53/p21, which is distinct from the G1/M checkpoint activities. After 
ATM dependent activation, Chk1 and Chk2 furthermore phosphorylate Cdc25C on Serine 
216 creating a binding site for 14-3-3 proteins. Binding of 14-3-3 proteins to Cdc25C, results 
in the nuclear export of Cdc25C to the cytoplasm thus inhibiting CDK1 activity (Bartek, et 
al., 1996). p53 is also activated to exert an inhibitory effect on CDK1 via p21 resulting in 
G2M arrest (Graves, et al., 2001; Blagosklonny & Pardee, 2002). 
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1.6.4.3.   The Mitotic Spindle Checkpoint 
 
In both mitosis and meiosis, the spindle checkpoint blocks progression from metaphase to 
anaphase when more time is required to allow chromosomes to achieve proper bipolar 
spindle attachment. Spindle microtubule disruption or a compromise in their connection to 
the kinetochores of chromosomes can delay the onset of anaphase when chromosomes fail to 
align completely at the metaphase plate. The primary target of the spindle checkpoint is the 
anaphase-promoting complex or cyclosome (APC/C) (Gorbsky, 2014). An E3 ubiquitin 
ligase, APC/C catalyses ubiquitination on several target proteins, thus enabling their 
recognition and degradation by the proteasome. During cell division its most important 
activator protein is cell division cycle (Cdc20), dually playing a key role within the 
checkpoint (Pesin & Orr-Weaver, 2008). Seven spindle assembly checkpoint genes (Mad1, 
Mad2, Mad3, Bub1, Bub2, Bub3 and Mps 1) are known to function at kinetochores to inhibit 
anaphase onset, or to mediate mitotic exit in the presence of spindle abnormalities (Encalada, 
et al., 2005). These act as APC/C inhibitors and form complexes in which the main endpoint 
is Cdc20 inhibition and APC/C inactivation as a consequence of this inhibition, causing a 
block at metaphase (Sudakin, et al., 2001). When most kinetochores are attached and 
chromosomes are aligned on the metaphase plate, Mad2 inhibition of APC-Cdc20 activity is 
ended. The active complex then ubiquitinates securin and allows the activation of separase, 
which cleaves cohesion. Loss of cohesion triggers chromosome segregation and the onset of 
anaphase. 
The destruction of securin allows the chromatids to separate, while proteolysis of cyclin B 
allows the cell to exit the mitotic state. The ubiquitin proteolysis of cyclin B is associated 
with the inactivation of CDK1, initiation of telophase, chromosome decondensation, nuclear 
envelope reformation, and cytokinesis. 
 
1.7 The Cell cycle and radiation  
 
Rapidly dividing cells, such as cancer cells, are more susceptible to radiation. The inherent 
cellular kinetics can result in different proportions of cells to be in different stages of the cell 
cycle at the time of radiation. This can influence the response to radiation treatment. In 
response to radiation, ATM activation plays and important role. It controls the initial 
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phosphorylation of several key proteins such as p53, Mdm2, BRCA1, Chk2 and Nbs1 in 
response to DNA damage (Zhou & Elledge, 2000). These activated proteins all exist as role 
players in genome integrity preservation and are paramount to the cells fate in the face of 
DNA damage. DSBs, one of the main causes of ionizing IR damage, is repaired by BRCA1. 
DNA repair takes place by non-homologous end joining (NHEJ) or homologous 
recombination (HR) (Sancar, et al., 2004). HR may play a more prominent role during the 
late S and G2 stages whereas early S and G1 DNA repair mechanisms are thought to be 
dictated by NHEJ (Pawlik & Keyomarsi, 2004). 
NHEJ, can occur throughout the cell cycle, predominantly in G0 and G1, and simply ligates 
the broken DNA. HR effects its repair mechanism by replicating an intact homologous DNA 
duplex, its requirement of an intact sister chromatid causes most of its operational activity to 
be within the S/G2 phase and is the most accurate form of DNA repair. NHEJ is a bit more 
complex and largely error prone. This is caused by limited processing of the DNA ends 
resulting in quick but often-times indelicate repair. Ironically, NHEJ largely exerts its effects 
with the aid of proteins that function as caretakers of the mammalian genome. NHEJ requires 
the DNA end-binding Ku complex (responsible for initial break recognition), a protein kinase 
which signals the break in DNA and activates repair proteins at the break, potential DNA end 
processing enzymes (for example Artemis) and a ligase complex which re-ligates the DNA 
(XRCC4-Ligase VI complex) (Burma, et al., 2006; Sonoda, et al., 2006). 
Throughout the cell cycle a variation in radiosensitivity can be observed. The late S-phase is 
the most radioresistant, G2M is most radiosensitive whilst G1 takes a more intermediate 
position. The greatest level of resistance shown by the S-phase may be due to a greater 
proportion of repair by HR than by NHEJ. Whereas the open structure of DNA might 
contribute to the radioresistance in G1. The high radiosensitivity seen in G2M is possibly 
caused by the poor repair competence (reduced enzyme access) and chromatin compaction 
(Bohm, et al., 2010). This is also further explained by cells switching off DNA repair during 
mitosis leading to telomere fusion inhibition (Otani, et al., 2016). 
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1.8. The cell cycle and gold nanoparticles 
 
The amount of studies exploring the effect of a particular agent’s ability to act in conjunction 
with radiation and affect the cell cycle has increased greatly. AuNPs are no exception in this 
regard. A study by Roa, et al., employing glucose-capped AuNPs (Glu-AuNPs) with 
megavoltage X-rays in prostate cancer revealed a 24% enhancement in radiation sensitivity 
due to AuNPs. An increase in cells stalled in G2/M and to a lesser extent in S-phase could be 
seen when compared to controls (Roa, et al., 2009). Another study by Geng, et al also 
showed an increase in radiosensitivity in ovarian carcinoma cells caused by Glu-AuNPs. 
Similarly, a significant increase in the cell fractions in G2/M was seen with an increase from 
18.4% in Glu-AuNP treated cells in G2/M to 40.5% of cells in cells treated with Glu-AuNPs 
and X-ray irradiation (Geng, et al., 2011). 
 
 
 
 
Figure 1.12: Interactions between the DNA damage response pathways 
and DNA repair networks (Sancar, et al., 2004) 
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EXPERIMENTAL AIMS 
 
AuNPs have been identified as effective radiosensitizers following bombardment with low 
energy (e.g. 200 – 500 keV) X-rays, leading to the release of Auger electrons that can induce 
localised ionising damage to cells.  
Since limited studies are currently available on the dose enhancement effect of AuNPs in 
clinical proton therapy, this project focused on the response of Chinese Hamster Ovary 
(CHO-K1) cells treated with AuNPs followed by exposure to 200 MeV protons at NRF 
iThemba LABS, Faure. Two types of AuNPs, synthesized using cardamom (green synthesis) 
and commercially obtained AuNPs (5, 10 and 50 nm) were used in this study and uptake and 
cytotoxicity was evaluated for CHO-K1 cells.   
The aim of this study was to investigate and compare the interaction between clinical proton 
treatment and AuNPs by: 
a) Performing time-and dose dependent exposure studies in order to determine the 
effect of the synthesized and commercial AuNPs on cell survival. 
b) Studying morphological changes induced by the different AuNPs with 
haemotoxylin and eosin staining 
c) Determining the interaction between AuNPs and protons of clinical energy, at 
various positions in the SOBP, by using the micronucleus assay and clonogenic 
cell survival assay 
d) Investigating the effects of AuNPs on their own and in combination with proton 
radiation on cell cycle progression 
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Chapter 2:  MATERIALS AND METHODS 
2.1 AuNPs 
2.1.1 AuNP synthesis (Green Chemistry)   
 
Gold nanoparticles were fabricated by means of a bottom up method using Elattaria 
Cardamomum extract as a reducing and stabilizing agent of Tetrahydrochloroauric acid 
(HAuCl4 
 3H2O) as described by (Singh & Srivastava, 2015). Parameters such as temperature, 
HAuCl4 3H2O quantity and seed processing as part of extract preparation were varied in order 
to observe its effect on AuNP synthesis. The solvent volume was kept consistent at 100 ml 
dH2O and the general format of AuNP synthesis involving solvent, reducing agent and gold 
salts (HAuCl4 3H2O) was followed. 
2.1.2 Spice preparation and processing 
 
Cardamom seeds sourced locally were removed from the pods. 0.5 g whole seeds or 0.5 g 
crushed seeds were used in the synthesis. This specific weight was used as preliminary results 
in our laboratory proved it to yield AuNPs with the narrowest size distribution.100 ml of 
dH2O and the seed pods were added to a glass beaker and the synthesis procedure followed 
according to the parameter to be varied. 
 
2.1.3 Temperature dependent synthesis 
 
2.1.3.1 Temperatures between 55-85 ° C 
  
The solvent containing the prepared seed pods was placed upon a heat stir plate and allowed 
to heat up to 55oC, 65oC, 75oC and 85oC respectively. After 5 minutes exposure to a specific 
temperature, a magnetic stirring bar was added to the heated solution at medium speed and 
allowed to spin for a further 4-5 minutes. 300 µl of HAuCl4 was then added to the solution 
resulting in an instant observable colour change from golden yellow to wine red or deep 
purple indicating the reduction reaction of HAuCl4∙3H2O  to Au2+ and thus AuNP production. 
For all NP solutions, wine red coloured solutions were considered relatively stable and 
monodisperse whereas grey and purple solutions were considered to contain a high level of 
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aggregation as described by (Huang & El-Sayed, 2010). AuNPs employed in stability over 
time studies were stored at 4oC however, for all other experiments Car-AuNPs were 
synthesized when required. 
2.1.3.2 Synthesis at room temperature (RT) 
 
Heatless synthesis required the NP solution to be made up as stated above with the immediate 
addition of 300 µl of HAuCl4. The solution was then left at RT (standard temperature (25
oC) 
and pressure) overnight and the resultant colour change from clear or amber to varying 
shades of purple or grey was considered an indicator of successful NP production within 
solution at RT. Thereafter the nanoparticles were filtered using Munktell filter paper (Lasec) 
to remove any debris and bulk toxins produced as by-products of the synthesis procedure. 
This filtration method was followed for all Car-AuNP synthesis procedures. 
2.1.4 Commercial gold nanoparticles (AuNPS). 
 
Citrate stabilized AuNPs (5 nm, 10 nm and 50 nm) were purchased from Sigma Aldrich 
(Johannesburg, South Africa). AuNPs were stored at 4oC to ensure stability over time and 
filtered through 0.2µm filters (Whattman, Lasec) just prior to treatment ensuring AuNP 
sterility prior to treatment exposure. 
2.1.5 AuNP treatment 
 
The following mathematical scheme was used to determine the volume of commercial AuNP 
solution that was needed to treat the cells with the required concentration of AuNPs. 
The radius was used as a starting point to determine diameter and subsequently derive 
particle per ml (parts/ml) that is later converted to a given concentration. 
r = 
10×10-7
2
 
  = 5 × 10-7 (radius of particle in cm) 
The radius of each AuNP was adjusted based on the size specifications of the manufacturer. 
Next, the volume of one particle in cm3 is calculated where 𝜋 = 3.142 
V = 
4
3
 ×π×r3 
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     = 
4
3
 ×π× (0.005)3 
     = 5.23×10-7 cm3 
The previously calculated volume is then used to determine the mass of the particles where 
𝜌 is the density of Au in g/ml (𝜌 = 19.3 g/ml); 
M = V×𝜌 
     = 1.012 × 10-17 
Thus the number of particles needed: = 
10×10-6
M
  (for 10 µg/ml) 
                                      = 9.885× 1011 
According to the indicated quantities of AuNPs by suppliers Sigma Aldrich, the number of 
particles per ml in 25 ml of an AuNP colloidal solution is 5.98 ×1012. 
Volume of AuNPs removed to yield 10 µg/ml = 
Number of particles Needed
Particles per ml of AuNP solution
 
  =    
 
Consequently the volumes were adjusted to ensure higher concentrations and or different 
sizes of AuNPs. 
2.2 AuNP Characterisation 
 
Physicochemical properties of nanomaterials contribute towards their behaviour in biological 
systems (Treuel, et al., 2014). Characterization of AuNPs is paramount in attaining reliable 
data with high translational output. Characterization procedures are needed to explain the 
NPs as chemical species which are highly reactive, with surface charge and particle size most 
often being identified as the cause for NPs reactivity to constituents in biological 
environments resulting in effects such as cellular uptake, toxicity and dissolution 
(Battacharjee, 2016).  
 
 
0.165 (Volume to taken out of bottle to yield 
10 µg/ml concentration of 10 nm AuNP.) 
 
0.165 (Volume to t ken out of bottle to yield 
10 µg/ml concentration.) 
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2.2.1  UV-visible (vis) spectroscopy 
 
By exploiting the principle of SPR, the UV spectrum can be used to draw conclusions about 
the size and stability of the AuNPs in suspension (Balog, et al., 2015).UV-vis spectra of 
AuNPs were recorded as function of wavelength using a POLARstar® Omega (BMG 
Labtech) UV-vis spectrophotometer from 400- 800 nm at a path correlation of 2.94 and 
resolution of 1 nm. 
 
2.2.2  Zeta Potential and Dynamic Light Scattering (DLS) determination 
 
Zeta potential (ZP) analysis is a technique used to determine the charge of nanoparticles 
within colloidal solutions whilst DLS is a spectroscopic technique used to determine the 
average hydrodynamic size of nanoparticles (Zimbone, et al., 2011). In order to execute the 
given characterization methods, 1 ml of AuNPs were placed into cuvettes or capillary tubes 
for DLS and ZP measurements. AuNP solutions were subsequently analysed using a 
Zetasizer Nano ZS (Malvern Instruments). Information was retrieved in the phase analysis 
light scattering mode at 25oC.  
2.2.3 Stability Testing 
 
Prior to AuNPs interacting with living cells or organisms, their surfaces are confronted with 
biological fluids such as cell culture medium, lung fluid or blood, whose components will 
inevitably interact with the NP surface. It is important to precisely understand the behaviour 
of these AuNPs in biologically relevant surroundings at a basic level which is crucial in 
developing any kind of nanomaterial of subsequent medical application. 
 Following a representative model system developed by Balog et al, AuNPs were incubated 
in commonly used buffers and cell culture media for 24 hours reflecting the longest 
incubation period of the AuNPs within cultures during experimental exposure scenarios 
(Balog, et al., 2015). Each particle type was incubated in four different increasingly 
biologically complex media namely (Figure 2.1) i) Phosphate Buffer (PBS) ii) Bovine Serum 
Albumin (a high molecular weight protein and major component of serum (5 mg/ml) iii) 
RPMI 1640 medium and iv) RPMI 1640 medium supplemented with 10 % FBS at 25oC and 
37oC. Additionally, the naked NPs (green) were tested over time to ascertain their stability in 
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storage (4oC). Commercial AuNPs were excluded from the time based stability tests due to its 
prior stabilization within a citrate buffer thus conferring an established stability over time in 
storage. Upon the completion of the respective incubation periods, AuNPs were characterized 
via UV-vis spectroscopy as previously described. 
2.2.4 Transmission Electron Microscopy (TEM) 
 
In order to visually confirm the presence of AuNPs within solution, AuNP samples were 
prepared as described above at 85 o C with crushed and whole seeds in order to ascertain 
whether or not seed preparation influenced nanoparticle size and shape. TEM is the most 
common and accurate technique for obtaining data about AuNP size and size distribution 
(Amendola & Meneghetti, 2009). TEM was performed at the University of the Western Cape 
Physics department using a FEI Tecnai G2. TEM images taken of commercial nanoparticles 
by AuNP suppliers (Sigma Aldrich, Johannesburg South Africa) were used as visual 
confirmation of AuNP size. 
2.2.4.1 Sample Preparation 
 
Samples were prepared by drop-coating 20 µl of AuNP solution onto a carbon coated copper 
grid and allowed to dry for approximately 10 minutes under a Xenon lamp. Once dried, the 
samples were analysed under the microscope. 
Figure 2.1: Example of the colour change in the biological media seen after a 24 hour incubation 
period at 37oC and 25oC with AuNPs, 
 
 
http://etd.uwc.ac.za
  
 
 
31 
 
Transmission electron micrographs were collected using an FEI Tecnai G2 20 field-emission 
gun (FEG) TEM, operated in bright field mode at an accelerating voltage of 200 kV.  
2.2.4.2 Energy dispersive X-ray spectroscopy (EDS) 
 
In addition to image production by TEM via transmitted electrons through the sample, more 
information can be gained from electrons interacting with the sample. Atoms within the 
sample produce X-rays as a by-product of their interaction with the transmitted electrons. 
These X-rays carry information as to the type of atoms present and can be retrieved by 
changing the detector of the TEM. This information is displayed as a spectrum identifying the 
elements present as elemental maps (DSimaging, 2013). This technique was used to confirm 
that the nanoparticles imaged were in fact composed of gold. EDS spectra were collected 
using an EDAX liquid nitrogen cooled Lithium doped Silicon detector. 
2.3 AuNP uptake 
 
In order to determine whether or not AuNPs were endocytosed into the cells, inductively 
coupled mass spectrometry (ICP-MS) was used. ICP-MS was performed at Stellenbosch 
University using Aqua Reagia ( 1:1 HNO3, HCL) to dissolve the AuNPs and allow the 
detection of the quantity of gold atoms in solution and subsequent conversion of this quantity 
to parts per million (ppm). Quantities yielded were then correlated to the concentrations with 
which we exposed exponentially growing cells to 2.5, 5 and 10 µg/ml of 10 nm and 50 nm 
AuNPs. This quantity was then converted to represent the amount of AuNPs endocytosed in 
parts per billion per cell (ppb/cell). 
2.4 Proton Radiation 
 
For the experiments involving high concentrations of smaller AuNPs, cell suspensions were 
irradiated in sterile 2 ml cryogenic vials (NEST Biotechnology Co., Cat. No. 607101) at 3 
different depths in the primary 200 MeV proton beam (collimator aperture: 30 mm diameter, 
R50 beam range: 100 mm, SOBP: 31 mm). An absolute calibration water tank with Perspex 
walls was used for this experimental set-up. 
The chromosomal damage tests with the larger AuNPs (50 nm), was executed by irradiating 
the adhered cell monolayer attached to the side wall of the culture flask making it possible to 
irradiate them in a thin monolayer (<1 mm) perpendicular to the beam direction at 3 positions 
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along the SOBP, including a position in the distal fall-off which required high precision 
positioning (Figure 2.2). Culture flasks were irradiated in a phantom consisting of several 
thin Perspex blocks. Water equivalent depths were simulated by interposing the Perspex 
blocks of varied thickness in front of the flasks (Figure 2.3). All irradiation exposures were 
performed at the NRF-iThemba LABS. 
All experiments involved some of, or all of the irradiated positions depicted in Figure 2.2. 
The entrance plateau was included in the bulk of the experiments in which it served as an 
internal reference/ standard position in order to merge the data from different experiments. 
Figure 2.2: Schematic depiction of irradiation conditions for proton experiments. Flasks containing 
the treated and non-treated cell monolayers were irradiated at different depths along the SOBP. The 
entrance plateau position served as a reference dose to which other irradiated depth conditions were 
compared. 
 
Figure 2.3: Images of experimental setups for proton experiments A) shows the Perspex containing 
the T 12.5 flasks B) shows the perspex walls surround the flasks in it’s correct orientation prior to 
proton radiation 
B 
A 
A 
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2.5.   Cell line 
 
Chinese hamster ovary (CHO-K1) cells, an epithelial cells line are derived from ovaries of 
the Chinese hamsters it is a well-studied cell line in radiation, genetics, toxicity screening, 
nutrition and gene expression (Wurm, 2004). The CHO-K1 cells were gifted by Prof. J 
Slabbert (NRF-iThemba LABS, Somerset West, Cape Town). 
 
2.5.1 Cell Culture Conditions 
 
CHO-K1 cells were maintained in RPMI 1640 medium, supplemented with 10% Fetal 
Bovine Serum (FBS) supplied by GIBCO, 1 % Pencillin (100µg/ml) and Streptomycin 
(100µg/ml), respectively. Cells were allowed to grow under standard conditions of 37oC, 5% 
Carbon dioxide and 95% humidity prior to harvesting for experimental purposes. 
  
2.5.2 Cell Proliferation 
  
The crystal violet assay is a colorimetric assay used for the quantification of DNA in 
response to treatments. Principally, crystal violet is a dye that accumulates in the cell nucleus. 
The solubilized dye is measured photometrically and the amount of dye absorbed correlates 
with the nuclear DNA content and thus with cell number (Vega-Avila & Pugsley, 2011). The 
optical density observed is converted and expressed as a function of percentage depicting the 
effect of AuNPs on the proliferative capacity of the cells when compared to controls 
(expressed as 100 %). Due to the plasmonic nature of AuNPs, the wavelength of AuNPs 
overlaps with various colorimetric substances resulting in the production false positive or 
negative results. Due to the absorbance of crystal violet (570 nm) this spectral overlap is 
prevented as the difference in absorbance is about 10-60 nm in wavelength between the 
AuNPs and crystal violet. 
Due to the doubling time of CHO-K1 cells, 2500 cells/well were seeded into 96-well tissue 
test plates (TPP) (Sigma Alrich) and allowed to attach and duplicate overnight. Cells were 
treated with 50 µg/ml of the 5 nm, 10 nm and the Car-AuNPs for 4 hours. Quantities of 50 
nm AuNPs at a 50 µg/ml concentration were determined to yield high volumes of the 50 nm 
stock solution (refer to mathematical scheme in section 2.1.5). This would result in a high 
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ratio of AuNPs to media. Distortions in treatment conditions were determined. Following 
this, 5 and 10µg/ml exposures for 4 and 24 hours respectively, were selected for the 50 nm 
AuNPs. Cells without AuNP treatment served as controls. Following the respective 
incubation periods, treatment-containing media was aspirated and the cells fixed in 100 µl of 
2.5% glutaraldehyde (Applichem) for 15 minutes. Cells were then stained with crystal violet 
for 30 minutes and subsequently rinsed with water. The plates were allowed to air dry. Once 
dry, 200 µl of 0.1 % Triton-X (Sigma Aldrich) was added for 30 min in order to lyse the cells 
and consequently free the bound crystal violet from nuclear constituents. 100 µl of the 
solution was then transferred to a 96-well flat bottom plate (greiner bio-one) and 0.1 % 
Triton-X added to an additional lane to serve as a blank. The plates were read at 570 nm 
using a UV-vis spectrophotometer and the optical densities recorded were converted to a 
percentage to assess changes in cell proliferation. 
 
 
 
 
2.5.3 MTT Assay 
 
The MTT cell viability assay is used to determine cytotoxicity of treatments (Tully, et al., 
2000). A water soluble tetrazolium salt, MTT (3-[4,5 – dimethylthiazol-2-yl] - 2,5 
diphenyltetrazoliumbromide) (Sigma-Aldrich, Johannesburg, South Africa) is converted to an 
insoluble formazan (causing a purple colour change) by cleavage of the tetrazolium ring by 
succinate dehydrogenase within the mitochondria. Due to the permeability of the formazan 
Figure 2.4: Image of the solubilized crystal violet dye upon addition of the detergent reagent 
(0.1 % Triton-X). Purple colour of the dye demonstrates that the wavelength at which optimal 
absorption will occur will be longer than that of the AuNPs due to where the purple colour lies on 
the colour spectrum in comparison to the red wine colour of successfully synthesized AuNPs.  
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product, it only accumulates in healthy tissue and the level of formazan can be directly 
correlated to viable cells able to convert MTT (Fortakis & Timbrell, 2006). The assay was 
thus used to assess the effect of 1.8 cineole (active compound in cardamom phytochemical 
complex), on the cells and determine the optimal treatment concentrations with which to 
apply 1.8 cineole in order to correlate the effect of the active compound to that of the Car-
AuNPs.  
According to Murata, et al, the 1.8 cineole (Sigma-Aldrich, Johannesburg, South Africa) 
exhibited inhibitory effects in colon cancer cells (Murata, et al., 2013). Thus concentrations 
increasing at 5 µl/ml increments from 5-20 µl/ml were explored according to the exposure 
conditions described by (Murata, et al., 2013). Exponentially growing cells were seeded into 
96-well plates, allowed to attach overnight and treated under the aforementioned conditions 
with the addition of a negative control (cells without AuNP exposure). The experimental 
protocol outlined by the ATCC® for the MTT assay was used to execute the experiment.  
 2.5.4 Mitotic Index 
 
Mitotic index was used to examine the influence that AuNPs and 1.8 cineole had on the 
morphology and mitosis of the cells. The haemotoxylin and eosin staining method was used 
to differentially stain dividing cells (for mitotic phase identification) to allow for the 
quantification of the effects that the change in environment had on cell division. 
10 000 cells/ coverslip (flame sterilized) were seeded into six well plates and allowed to 
adhere to the coverslips within the culture vessel overnight. Coverslips (Lasec) were flame 
sterilized using 100% ETOH under aseptic conditions. Cells were then exposed to 20µl/ml of 
1.8 cineole and 5 µg/ml or 10 µg/ml of AuNPs for 24 hours. Cells without 1.8 cineole and 
AuNPs were considered controls. Upon completion of the incubation period, cells were fixed 
in Bouins fixative (Sigma Aldrich) for 20 minutes, washed in 70 % ETOH (Sigma Aldrich) 
and rinsed in water. This was followed by staining the cells in haemotoxylin (Sigma Aldrich) 
for 12 minutes followed by a 1 minute rinse step. The cells were then stained in eosin (Sigma 
Aldrich) followed by another rinse with water for 1 min. Finally, the cells were dehydrated 
by sequentially placing them in 70%, 90% and 100% ETOH for 2 minutes respectively 
followed by a final 2 minute exposure to Xylene (Sigma Aldrich). The stained cell containing 
coverslips were then mounted with xylol (Sigma Aldrich) onto slides (Lasec). 3 Replicates of 
each exposure scenario were scored using a compound light microscope (Zeiss) at 40× 
magnification, 
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The mitotic index was expressed graphically by plotting the percentage of diving cells using 
the following equation: 
(Prophase+Metaphase+Anaphase+Telophase)
N (cumulative number of dividing cells)
 ×100%. 
 
2.5.5  Clonogenic cell survival assay 
 
The clonogenic cell survival assay determines the ability of a cell to proliferate and to form a 
large colony or clone. This is particularly relevant to radiation biology as cells are generally 
regarded as been “killed” by radiation if they have lost their proliferative integrity, not by 
whether they physically survive in population (Bohm, et al., 2010). Hence, a cell survival 
curve can be defined as the relationship between the dose of an agent used to produce an 
insult and the fraction of cells retaining their ability to replicate (Munshi, et al., 2005). 
The clonogenic cell survival assay was used to assess the radiation dose enhancement 
capabilities of AuNPs and the effect of AuNPs on cell survival. Preliminary experiments 
provided the plating efficiencies (PE) of the CHO-K1 cells and the effects of AuNPs on the 
proliferative integrity of the cells upon insult by irradiation. PE refers to the percentage of 
cells seeded into a dish that finally grow into a colony.  
 
 
 
 
 
 
 
 
 
 Figure 2.5: Graphic depiction of the steps 
involved in the clonogenic cell survival assay 
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Preliminary experiments prior to proton irradiation experiments aided in determining the 
quantities of cells required to compensate for the loss of cells due to irradiation in order to 
obtain an equal initial quantity of 200 colonies per plate for all samples. 
Exponentially growing cells were seeded (750 000/ flask), and allowed to attach. The cells 
were then treated with a 37 µM concentration of 50 nm AuNPs and incubated for 24 hours 
prior to irradiation. The conditions of the experiment also included a non-irradiated AuNP 
control along with a negative control containing no AuNPs and no irradiation to determine 
the PE. Additionally, irradiated controls without AuNPs for all dose points were included. 
The cells were then irradiated (6 Gy protons) in the entrance plateau, proximal and middle 
positions of the SOBP. Immediately after irradiation, the cells were trypsinized and counted 
using a haemocytometer. Cells were then seeded in triplicate (Figure 2.5). Plates containing 
cells were placed back into the incubator to allow proliferation into colonies (≥50 cells per 
colony) over a period of 6 days. Upon completion of the 6 day period cells were fixed in 
1:8:1 acetic acid, water and methanol for five minutes, stained with 0.01% amido black for 30 
minutes, washed with fixative and allowed to air dry. The blue stained colonies were then 
scored by counting all the individual colonies (that met the abovementioned cell number 
requirements) and the change in surviving fractions in relation to dose, plotted for further 
analysis. 
This high dose of 6 Gy was selected due to the minimal effect on the surviving fractions 
commonly seen when applying a 4 Gy dose and moreover a 2 Gy dose which is often 
comparable to the negative control in cell number. Dilution routes calculated using pre-
determined plating efficiencies via γ-ray irradiations (Cobalt-60 source) as reference data, 
were followed and the required quantities seeded accordingly into 3 petri dishes (60×20mm, 
Greiner). 
Figure 2.6: Image depicting an example of the colonies upon completion of the CSA assay. 
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2.5.6 Chromosomal damage 
 
The micronucleus assay is one of the preferred methods for assessing chromosome damage 
because the assay enables the reliable measurement of chromosome loss and chromosome 
breakage (Fenech, 2000). Micronuclei (MNi) (Figure 2.7) are small extranuclear bodies that 
stem from chromosome fragments or whole chromosomes that lag behind at anaphase during 
nuclear division (Vral, et al., 2011). The cytokinesis block micronucleus (CBMN) assay is 
often used to measure MNi, because scoring is restricted to once-divided binucleated cells 
(BN), which specifically express MNi. This restriction prevents confounding effects caused 
by suboptimal or altered cell division kinetics (Fenech, 2007).  Furthermore, the CMBN 
method allows for the accumulation of virtually all cells in the BN stage regardless of their 
division kinetics making the test highly sensitive (Luzhna, et al., 2013). 
Exponentially growing cells were seeded into 25 cm3 (NEST) flasks at 750 000 cells/flask 
and allowed to attach overnight. Cells were subsequently treated with 50 µg/ml of the 10nm, 
5 nm or Car-AuNPs for 4 hours. Immediately prior to irradiation the cells were trypsinized 
and placed into cryovials (NEST). Cells were irradiated with a 2 Gy dose in suspension 
within a water phantom. Immediately post-IR, cytochalasin B (Cyt-B) (an inhibitor of 
microfilament assembly requirement for cytokinesis completion), was added directly to the 
suspension at a concentration of 1 mg/ml. The Cyt-B containing cell suspensions were 
consequently seeded into petri dishes (Greiner) containing coverslips. The cells were allowed 
to grow overnight and were fixed in 3:1 methanol, acetic acid exactly 24 hours after Cyt-B 
addition and allowed to air dry. Immediately prior to scoring, cells on coverslips were stained 
with 0.1% aqueous solution of acridine orange (AO) for 1 minute and rinse with Gürr buffer 
for 1 minute. The stained coverslips were then mounted onto slides (Lasec) using Gürr buffer 
as a mounting solution. The slides were then scored using a fluorescent microscope (Zeiss), 
with a FITC filter for optimal visualization of the BN containing MNi. 
For the 50 nm AuNPs, the entrance plateau, proximal, middle and distal positions of the 
SOBP along with the 80% Dmax position in the distal fall-off were used for the irradiation 
with 2 and 4 Gy proton doses. Exponentially growing cells were seeded at 750 000 cells/flask 
into 12.5 cm3 (Flacon) flasks and allowed to attach. The cells were then treated with 10µg/ml 
(37µM) of AuNPs for 4 and 24 hours respectively. The change in concentration was selected 
due to the large amount of 50nm AuNPs that would be required within in media to obtain a 
http://etd.uwc.ac.za
  
 
 
39 
 
50µg/ml concentration. The low media: AuNP solution ratio could possibly result in a high 
level of cytotoxicity prior to irradiation due to a lack in nutrient supply to the cells. 
Additionally, a greater level of dose enhancement was expected to be exhibited by the 50 nm 
AuNPs in comparison to the smaller AuNPs which would effectively saturate the cells with 
damage and create difficulty visualizing MNi when scoring. Finally, according to findings by 
Jain, et al, AuNPs were shown to have radiosentization effects at optimal concentrations of 
12 µM (Jain, et al., 2011). Thus, the concentration applied in this study was reduced 
accordingly so that a suitable concentration (in µM) was applied to the CHO cells. 
The cells were irradiated as an attached monolayer in a T12.5 culture flask at different 
positions. Immediately after irradiation cyt-B was added at a concentration of 1mg/ml. The 
cells were then incubated overnight and 24 hours post-IR trypsinized, centrifuged at 1000 
rpm for 8 minutes and permeabilized with 0.045 M cold potassium chloride (KCL). The cells 
were then centrifuged again and fixed in 1:10:11 acetic acid, methanol and ringers solution 
overnight. The following day, the cells were pelleted by centrifugation and the fixative 
aspirated followed by the addition of 10:1 methanol acetic acid fixative resuspension of the 
cells within the fixative. From this cell suspension, 40 µl was used to drop coat slides and 
allowed to dry. The slides were then stained with AO by suspending cells in AO, followed by 
suspension in Gürr Buffer, covered with a coverslip (using Gürr Buffer as a mounting 
solution) and scored manually using a fluorescent microscope (Zeiss). 
Scoring criteria as set out by (Fenech, 2000; Fenech, 2007) were used for the evaluation. 
Briefly, cells that may be scored for MNi frequency must exhibit the following 
characteristics; (i) cells should be binucleated (ii) two nuclei should exhibit defined 
membranes within the same cytoplasmic boundary (iii) the two nuclei should exhibit the 
same morphological characteristics (iv) a nucleoplasmic bridge connection is allowable to a 
size range of a ¼ of the nuclear diameter (v) nuclear boundaries should be distinguishable 
especially in the case of overlapping nuclei and finally (vi) cytoplasmic boundaries of 
adjacent cells should be individually distinguishable. For each condition the total number of 
MNi per 500 BN cells per slide, was analysed. All conditions were scored in triplicate and the 
average per triplicate used to express the change in MNi quantity per condition. 
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Figure 2.7: MNi and nucleoplasmic bridge formation in cells 
undergoing nuclear division. This is only observable in cells 
undergoing nuclear division and can be recognized by their BN 
appearance after cytokinesis blocking with Cytochalasin-B (Cyt-
B). Image excerpted from (Fenech, 2007). 
 
 
 
 
 
 
 
 
 
 
 
2.5.7 Interaction Indices 
 
Interaction between AuNPs and protons were suggested by calculating a factor representative 
of the interaction between the combined treatments. The following equation was applied to 
data yielded from the CBMN and CSA assays. A sensitization interaction between protons 
and AuNPs is considered to exist when Unity (U) > 1. Conversely when U<1 no interaction 
occurred. Unity is the preferred indices as for interaction investigation as outline by Prof. J 
Slabbert. 
Unity = 
Combination of Treatment (AuNPs+IR)
Separate treatments (AuNPs)+(IR)
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2.5.8 Cell Cycle Kinetics 
 
The outcome of irradiation is affected by the cell cycle (Otani, et al., 2016). In this study, 
flow cytometry was used to determine the combined effect of AuNPs and protons on the cell 
cycle. Flow cytometry enables the identification of cell distribution during various phases of 
the cell cycle. Discrimination between the phases of the cell cycle is based on their respective 
DNA contents made distinguishable by a fluorescent dye, propidium iodide (PI) which binds 
stiochiometrically to DNA. Principally, the stained material has incorporated an amount of 
dye that is directly proportional to the amount of DNA within the cell population (Nunez, 
2001). Different quantities of DNA are expressed during the different phases of the cell cycle 
making the aforementioned distinction possible. The flow cytometer operates by introducing 
cells into an artificial flow and hydrodynamically focusing them into a single file. Laser 
induced fluorescence and/ or scattered light reflected off cells can be detected by 
photodetectors (Figure 2.8) (Tanev, 2009).  Slight deflection of some of the photons that hit 
the edge of the cell (forward scatter) corresponds to the size of the cell, whereas photons 
scattered at right angles to the cell indicate the inner complexity and granularity of the cells 
(Dhawan & Sharma, 2010).  A resultant dot graph representing the respective amounts of 
scatter is then plotted by the flow cytometer and replotted into a histogram depicting the 
different phases of the cell cycle and the extent to which a treatment induces accumulation of 
cells in a specific phase. 
 
 
 
 
 
 
 
 
 
Figure 2.8: Graphic depiction of forward and side scatter used to 
measure cell size and inner complexity within a flow cytometer. 
www.oncohemakey.com 
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1×106 cells were seeded into 25 cm3 flasks and allowed to attach overnight. The cells were 
then exposed to 50 µg/ml of 5, 10 or 50 nm AuNPs for 4 hours prior to irradiation or 10 
µg/ml of AuNPs, 24 hours prior to irradiation. Upon exposure to the AuNPs for the allotted 
time frames, media containing the AuNP suspensions were removed and the cells replenished 
with fresh media. Cells were then irradiated with a 6 Gy dose of protons at the reference 
position, entrance of the SOBP, middle of the SOBP, the proximal end of the SOBP and the 
40% Dmax positon (distal fall-off). Cells were then returned to the incubator immediately 
after irradiation and allowed to incubate for 8 hours. Upon completion of the 8 hour time 
frame, cells were harvested, concentrated by centrifugation for 6 minutes at 900 rpm. This 
was followed by membrane permeabilization using 5 ml of ice-cold 95 % ethanol (EtOH) 
which also served as a fixative in which the cells were stored at -20o C overnight. 
Subsequently the EtOH was removed by centrifugation at 1400 rpm for 5 min (25o C). The 
cells were then washed with PBS (pH7.4) twice and the cells concentrated followed by the 
removal of supernatant from the pellet to which 1 ml of propidium iodide (PI) was then added 
and the cell pellet resuspended within the PI. The cell suspensions containing the PI, was left 
for 10 min at RT prior to analysis with the flow cytometer. 
A BD ACCURI-6 flow cytometer was used to analyse the cells employing a 488 nm laser and 
recording 10 000 events per sample. The BD ACURRI 6 software was used to apply a gate to 
the resultant plots that were consistent for all cell populations. Data collected was 
subsequently analysed according to scatter as described by Dhawan & Sharma in which it is 
explained that the changes in side scatter detected can be directly correlated to AuNP uptake 
(Dhawan & Sharma, 2010). Furthermore, according to Roa, et al., RCGG is a parameter that 
depicts the cell status at the time of radiotherapy and is derived based on the measured cell 
changes due to AuNP treatment. RCGG can thus be used to deduce cellular radiosensitivity. 
Hence, the most sensitive and radioresistant phases of the cell cycle is taken into account. 
With a modification on the calculation provided by (Roa, et al., 2009), with the S-phase in 
lieu of the G0/G1 phase being selected as the most radioresistant phase, RCGG was 
calculated by:  
RCGG = 
Value of G2M phase (%)
Value of S-phase (%)
 
RCGG allows several derivations, the first, that a greater G2M leads to a larger RCGG, a 
smaller S-phase leads to a larger RCGG and a larger RCGG indicates a greater level of 
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radiosensitivity when compared to controls. RCGG was thus calculated in order to determine 
whether the AuNPs were able to effectively sensitize the cells when compared to cells that 
received protons without AuNPs. 
2.6 Statistical Analysis 
2.6.1 Cell Proliferation, MTT assay and Clonogenic cell survival assay 
 
GraphPad Prism 5 statistical analyses software was used to perform statistical analysis on 
data yielded from the crystal violet assay (GraphPad Prism version 5 for Windows, GraphPad 
software San Diego, California, USA). Predetermined standard deviations (Excel 2013) were 
used to plot error bars within the data and two-way analysis of variance (ANOVA) along 
with Bonferonni post-tests (post hoc) were used to obtain whether statistically significant 
differences existed among the exposure scenarios when compared to their controls and one 
another. Herein, variation between groups were considered statistically significant when p 
values were less than 0.05 (p<0.05), highly significant when p<0.01 and extremely 
significant when p<0.001. 
2.6.2 Mitotic Index  
 
The statistical analysis of mitotic index was completed via Medcalc (Schoonjans et al., 1995) 
(version 14.8.1). One way analysis of variance (ANOVA) was used to determine the 
significant differences between the control means and experimental groups. Error bars of ± 2 
standard deviations (SD) were used to show the influence of AuNP types on each sample in 
an experiment group. Student Newman Keuls tests were performed for all independent and 
pair-wise comparisons and results were considered statistically significant if p<0.05. 
2.6.3 Radiation Damage 
 
The radiation damage data from the CBMN assay was analysed at Stellenbosch University by 
Professor M. Kidd using Statistica. The data was assessed for normal distribution and 
subsequently analysis using the Kruskal-Wallis test to compare the means. Vertical bars on 
the data points were used to denote 0.95 confidence intervals whilst alphabetical letters were 
used to indicate statistically significant differences between means. For example; samples 
that were both labelled a do not statistically differ from one another. Samples labelled a and 
ab or bcd and abc were significantly different statistically indicated by the difference in 
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alphabetic letters and letter arrangements. Samples were considered statistically significant 
when the determined p-value was lower than 0.05 (p<0.05)
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CHAPTER 3: RESULTS 
 
3.1 Gold Nanoparticle Characterisation 
 
Car-AuNPs were synthesized by adjusting the parameters (temperature and degree of 
mechanical crushing of cardamom seeds) of the synthesis procedure in order to ascertain 
whether the shape and size of AuNPs are dependent on these parameters. The colours of the 
Car-AuNPs showed the same red hue when compared to the commercial AuNPs (Sigma 
Aldrich). Due to the unique optical properties of AuNPs, their UV-spectrum results in a 
particular ruby red colour when AuNP suspensions are stable (Huang & El-Sayed, 2010). 
Figure 3.1: Images depicting various  AuNP colloidal solutions used for treatment A) 
the difference between AuNPs synthesized by crushed (left) and whole (right) cardamom 
seed pods at 85oC B) Commercial AuNPs (from left) 5nm, 10 nm and 50 nm C) difference 
in colour of colloidal solution (from left) Car-AuNP, 5 nm AuNP, 10 nm AuNP and 50 nm 
AuNP  
A 
 
 
A 
 
B 
 
 
B 
 
C 
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3.1.1 Ultraviolet Spectrophotometry 
 
The absorption of each AuNP solution was measured via UV-vis spectrophotometry for the 
analysis of surface plasmon resonance (SPR) to determine AuNP presence, as well as 
approximate size and quantity (Huang & El-Sayed, 2010). SPR properties of AuNPs allows 
the determination of agglomeration levels based on the maximum wavelength at which 
AuNPs absorb light. The influence of AuNP size on SPR is affected by the absorption 
maximum (ʎ max) which increases from 520 nm to 570 nm for 20 nm AuNPs and 100 nm 
AuNPs respectively (Huang, et al., 2006). Therefore this increase in AuNP size red shifts the 
SPR wavelength and also increases the intensity (absorbance). The expected SPR peak for 
AuNPs that are uniform in size and shape is thus narrow and normally appears in the visible 
region staring at 520 nm (Huang & El-Sayed, 2010; Salata, 2004). 
Figure 3.2: The effect of temperature of the synthesis reaction on AuNP product.  
Figure 3.2 shows that AuNP synthesis using crushed cardamom seeds provided the product 
with the greatest level of stability, absorbance and narrowest SPR band width at 85oC. The 
result showed that the optimum synthesis temperature for Car-AuNPs was 85oC. 
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Figure 3.3: UV absorption spectra of Car-AuNPs.  Car-AuNPs synthesized from crushed and 
whole cardamom seeds at 85℃, showed a clear difference in AuNP quality as depicted 
visually and via a difference in absorbance. The absorbance of Car-AuNPs (crushed) ʎ max 
at a wavelength of 525 nm whilst the Car-AuNPs prepared by extract with whole cardamom 
seeds had a ʎ max of 590. 
 
Figure 3.4: UV absorption spectra of 5, 10 and 50 nm AuNPs.  
The ʎ max of 50 nm AuNPs was recorded at 536 nm, whilst the 5 and 10 nm AuNPs measured 542 
and 544 nm respectively (Figure 3.4). The larger ʎ max values of the 5 and 10 nm AuNPs indicates 
that agglomeration was present within the AuNP solutions whilst the ʎ max value of the 50 nm 
AuNPs shows that the 50 nm AuNPs were stable. 
ʎ
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3.1.2.  Dynamic Light Scattering 
 
DLS was used to determine the hydrodynamic sizes of AuNPs within suspension and obtain 
the level of dispersity in the size of the AuNPs expressed as an index known as the 
polydispersity index (PDI). “Monodisperse” AuNPs usually have narrow PDI ranges within 
values of 0.0-0.1. “Poloydisperse” NPs measure within a range of 0.1-0.4 and are considered 
moderately disperse within this range whilst a broad level of dispersity is usually denoted by 
PDI values that are greater than 0.4 (Nobbmann, 2014). The size distribution curves obtained 
are shown in Figure 3.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A 
B 
C 
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Results depicted in Figure 3.5 A represent the DLS measurements obtained for the 5 nm 
AuNPs. 5 nm DLS results show AuNPs that are polydisperse. However the analysis of the 
two peaks indicate that the majority of the AuNPs in solution are within the 10 nm range 
(Figure 3.5 B) (smaller sizes are usually more difficult to detect with DLS) indicating that the 
true size of the AuNPs are indeed 5 nm. The 10 nm and 50 nm AuNPs single DLS curves 
indicate moderate and narrow levels of size dispersity within the samples. The size 
distribution curves of the Car-AuNPs confirm the previously reported difference in quality of 
the AuNPs yielded via synthesis with extract of different seed preparations. The distribution 
curve for the crushed Car-AuNP (Figure 3.5 E) showed that the difference in extract 
preparation resulted in better AuNP size dispersions when Car-AuNPs were prepared with 
extract from crushed seeds rather than whole seeds (Figure 3.5 D). 
 
 
 
E 
Figure 3.5: The hydrodynamic sizes of AuNPs. A) 5 nm AuNPs B) 10 nm AuNPs C) 50 nm 
AUNPs D) Car-AuNPs (whole seed extract) E) Car-AuNPs (crushed seed extract) 
 
 
D 
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3.1.3. Zeta Potential 
 
The determination of surface forces on the surface of the AuNPs provides crucial information 
on the stability of the particles in dispersion. The magnitude of the ZP is predictive of the 
colloidal stability and NPs with a ZP greater than + 25mV and less than – 25mV, typically 
have high degrees of stability (nanoComposix, 2012).   
 
 
 
A 
C 
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Figure 3.6: Zeta Potential analysis of AuNPs. Barring the 5 nm AuNPs, all AuNPs were relatively 
stable and anionic. 
 
 
 
 
 
 
 
 
 
 
 
Sample name DLS Zeta Potential Polydispersity Index (PDI) 
5 nm AuNP 176.4 d.nm -44.1 mV 0.402 
10 nm AuNP 33.47 d.nm -32.8 mV 0.225 
50 nm AuNP 65.64 d.nm -35.1 mV 0.102 
Car-AuNP whole 176.1 d.nm -23.3 mV 0.440 
Car-AuNP crushed 191.4 d.nm -19.9 mV 0.242 
Table 3.1: DLS and Zeta Potential results. These results correspond to the size distribution curves 
(averaged) and zeta potential graphs depicted above.  
A clear discrepancy in size of the 5 nm can be seen with a high PDI of 0.402 (Table 3.1). The 
size distribution of the 10 and 50 nm are moderately disperse and yielded good result 
qualities. The charge of all AuNPs barring the 5 nm indicated stable nano-dispersions. The 
same discrepancy seen for the 5 nm AuNPs regarding size is noticeable for the Car-AuNPs 
which measured an average of 11 nm with TEM. 
  
D 
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Figure 3.7: TEM images of Car-AuNPs synthesized at 85oC where images on the left (A, C and E) 
depict crushed cardamom pod seeds and images on the right (B, D and F) show AuNPs synthesized from 
whole cardamom pod seeds.  
 
 
3.1.4. Transmission Electron Microscopy 
 
TEM was performed in order to visually confirm the presence of AuNPs, to visualize the 
morphological characteristics of the Car-AuNPs and to determine the core size and elemental 
composition of the AuNPs. 
F 
 
F 
A B 
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The images in Figure 3.7 reveal AuNPs that are largely similar in size with conformal shapes 
(spherical) in Car-AuNPs synthesized with crushed AuNPs whereas Car-AuNPs synthesized 
with whole cardamom seeds  produced AuNPs of various shapes (spherical, rod shaped, 
triangular, and pentagonal) and sizes. The TEM images allow a visual confirmation of the NP 
shape and affirm results obtained and outlined in Table 3.1. The core sizes of the Whole-
AuNPs were highly variable with measurements of 30 and 20 nm whereas the Crushed-AuNP 
measurements were within 10-12 nm size range (as measured by the technician). 
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3.1.5. Energy dispersive X-ray spectroscopy (EDS) 
 
EDS was performed in addition to TEM in order to determine the elemental composition of 
the NPs and confirm that Au atoms are present within the sample. The graphs presented in 
Figure 3.8 confirm that there are Au atoms present within the sample. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8: Elemental analysis results of AuNPs synthesized A) crushed cardamom seed pods and 
B) whole cardamom seed pods at 85oC. Multiple gold (Au) peaks confirms the successful synthesis of 
AuNPs. The presence of carbon (C) and copper (Cu) peaks are due to the carbon and copper coatings 
on the grid which the AuNPs were placed for TEM analysis. 
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3.1.6.  Selected area diffraction (SAED) 
 
SAED was the final confirmatory test used to identify the nature of AuNPs. Like EDS, it is 
performed in addition to TEM by changing the detector of the electron microscope. 
 
The elliptical rings containing bright spots are characteristics of crystalline AuNPs (Figure 
3.9). It could thus be deduced that AuNPs are crystalline in nature with a probable face 
Figure 3.9: Images depicting SAED results of Car-AuNPs synthesized at 85oC using A) crushed 
cardamom seed pods and B) whole cardamom seed pods. 
A 
 
A 
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centred cubic (fcc) unit cell structure that is characteristic of metallic crystalline structures 
(Page, et al., 2004). 
   
3.1.7. Stability testing 
 
Stability testing was performed in order to obtain the level of stability that AuNPs exhibit 
after exposure to cell culture media. AuNPs were incubated in commonly used buffers and 
cell culture media for 24 hours reflecting the longest incubation period of the AuNPs within 
cultures during experimental exposure scenarios. Each particle type was incubated in four 
different increasingly biologically complex media i) Phosphate Buffer (PBS) ii) Bovine 
Serum Albumin (a high molecular weight protein and major component of serum (5 mg/ml) 
iii) RPMI 1640 medium and iv) RPMI 1640 medium supplemented with 10 % FBS at 25oC 
and 37oC. 
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Compared to the normal spectra of the AuNPs seen in Figure 3.3 and Figure 3.4 
agglomeration is present upon the addition of media. This agglomeration is apparent from the 
spectral shift seen from ʎmax: 544 nm, to 535 nm (BSA), 530 nm (Media), 570 nm (PBS) 
and 540 nm (media and serum) for the 5 nm AuNPs. Though decreases in ʎmax values 
occurred, the increase in the SPR band width occurred and could be used as confirmation of 
AuNP agglomeration within culture media. 10 nm AuNPs wavelengths shifted from 542 nm 
to 525 nm (BSA), 520 nm (PBS), 582 nm and 540 nm (media and serum). Spectral shifts 
were also evident for 50 nm AuNPs with spectral curves seen from 536 nm to 544 nm (BSA), 
544 nm (media), 554 nm (PBS) and 552 (media and serum). Spectral shifts in the UV-
spectrum of Car-AuNPs was also visible with the recorded ʎmax increasing from 525 nm to 
544 nm (BSA), 536 (Media), 566 (PBS), and 550 nm (media and serum). The addition of 
BSA or media to the AuNP solutions resulted in negligible agglomeration within some 
samples whilst other AuNP solutions remained unaffected by the addition of the biological 
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Figure 3.10: Absorption profiles of AuNPs immediately after the addition of 
biological media to the respective AuNPs. A) represents Car-AuNPs B) 5 nm 
AuNPs C) 10 nm AuNPs and D) 10 nm AuNPs 
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media (50 nm). The greatest level of agglomeration across all samples was caused by the 
addition of PBS, whilst increased levels of agglomeration are indicated by the major shifts of 
AuNP spectra when compared to the effects of the other biological media.  
 
 
  A 
C 
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Figure 3.11: The Absorption spectra of AuNP solutions after a 24 hour incubation period with 
biological media. 24 hour spectral curves depict 25 o C incubation (top half of legend) and 37 o C 
(bottom half of legend) incubation temperatures.  
 
 
 
 
 
 
 
 
 
 
 
After 24 hours the 5 and 10 nm AuNPs exhibited similar levels of agglomeration at both 
temperatures (Figure 3.11 C and E) whilst the Car-AuNPs and 50 nm (Figure 3.11 A and D) 
AuNPs remained relatively stable. With the exception of Car-AuNPs, media, and 
supplemented media affected the spectral shifts the most. In all cases with upwards of 5 nm 
shifts in absorbed spectra for all samples along with SPR flattening when compared to 
absorbance profiles without biological media indicating AuNP agglomeration within the 
solutions. The AuNP agglomeration levels also increased when exposed to the 37 °C 
incubation temperatures as opposed to the 25 °C temperatures. 
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3.1.8. Gold Nanoparticle uptake (ICP-MS) 
 
ICP-MS was used to quantify the uptake of AuNPs in CHO cells and to correlate the 
difference in uptake between the 10 nm and 50 nm AuNPs. 
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Figure 3.12: Quantities of AuNPs taken up by CHO cells after a 24 hour incubation with 10 nm 
and 50 nm AuNPs. The decreased uptake of the 10 nm AuNPs at the highest concentration was 
treated as an outlier. 
 
Table 3.2: Estimated quantities of AuNP uptake after a 24 hour incubation period with 
increasing   concentrations of each AuNP type. 
 
 
 
 
 
Figure 3.12 illustrates an increase in uptake efficiency in response to an increase in AuNP 
concentration. The 10 nm AuNPs are taken up more efficiently than the 50 nm AuNPs as can 
be seen in Table 3.2. This higher uptake of 10 nm AuNPs in CHO cells is also clear in Figure 
3.12, where there is an increased uptake of 10 nm AuNPs (red square) when compared to 50 
nm AuNPs (purple dots) up to an AuNP concentration of 10 µg/ml. 
Key of 
concentration 
on graph 
Applied 
concentration of 
10 nm and 50 nm 
AuNPs 
Approximated 
amount  of 10 nm 
AuNPs 
endocytosed by 
cells 
Approximated 
amount of 50 nm 
AuNPs  
endocytosed by 
cells 
1 2.5 µg/ml 2.3 µg/ml 1.8 µg/ml 
2 5 µg/ml 4.5 µg/ml 3.6 µg/ml 
3 10 µg/ml 8.4 µg/ml 7.3 µg/ml 
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3.2  In vitro analysis 
3.2.1  Cell Proliferation  
 
The effect AuNPs on cell proliferation was investigated, using a crystal violet assay prior to 
irradiation experiments. The time frames of 4h (Figure 3.13 and 3.14) and 24 h (Figure 3.15) 
were used for these experiments, since they reflect the pre-incubation periods that were used 
to expose the CHO cells to AuNPs before proton radiation.  
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Figure 3.13 shows that the greatest level of cytotoxicity was exhibited by the 5 nm AuNPs, 
wherein 28 % reduction in cell proliferation was caused, whilst the 10 nm AuNPs reduced the 
cell proliferation by 13 % when compared to controls. The Car-AuNPs had an opposite, 
stimulatory effect on the cell proliferation of CHO cells increasing the cell proliferation form 
100 % expressed by controls to 115% in Car-AuNP treated samples. 
Figure 3.13: Effect of AuNPs on cell proliferation after 4 h incubation period. Bars labelled ***  
and ** depicts mean values that were significantly different from controls. *** (P<0.001) ** (P 
<0.01). 
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Figure 3.14: Effect of 50 nm AuNPs on cell proliferation after 4 hour incubation period. 50 nm 
AuNPs had a slight effect on cell proliferation after a 4 hour exposure period. Mean did not differ 
statistically significantly (p>0.05)  
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The 50 nm AuNPs caused minimal decreases in cell proliferation after 4 hours (Figure 3.14) 
resulting in a ~10 % decrease in cell population when compared to controls. One must note 
that a lower concentration of 50 nm AuNPs was used for the cell proliferation experiments 
compared to the 50µg/ml concentration used for the 4 h incubation experiments with the 
commercial 5 nm and 10 nm AuNPs and the Car-AuNPs (see Figure 3.13). This was done to 
limit the volume of 50 nm stock solution that had to be added to the cell culture as previously 
described in section 2.5.2.1 Cell proliferation. 
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Figure 3.15: Effect of larger AuNPs (10 nm and 50 nm) at low concentrations on cell 
proliferation after a 24 hour incubation period. The AuNPs exhibited very little to no effect on 
the proliferation of the cells when compared to their controls Means were not significantly different 
from control (P>0.05). 
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The 10 nm AuNPs had no effect on cell proliferation at lower concentrations (5 µg/ml) whilst 
at higher concentrations (10 µg/ml) cell proliferation was minimally decreased by 5% (Figure 
3.15). The 50 nm AuNPs reduced the cell proliferation by 4% (at 5 µg/ml) and 6% (10 
µg/ml) respectively. 
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Figure 3.16: The effect of different 1.8 cineole concentrations on cell viability. * indicates P value 
<0.05, ** indicates P value < 0.01 and *** indicates P value <0.001. 
 
 
3.2.2 Cell Viability 
 
In order to determine whether or not 1.8 cineole affected cell viability, the MTT assay was 
selected. Due to 1.8 cineole being a compound, spectral overlap did not have to be considered 
in this assay selection as was the case with AuNPs. The MTT assay could be performed in 
lieu of the crystal violet assay which allows rapid detection on the same day and requires less 
preparation but yields result outcomes that are as reliable and reproducible as the latter. 1.8 
cineole is the active compound of cardamom.  Accordingly, it was imperative to determine 
the optimal inhibitory concentration of 1.8 cineole in order to allow the correlation between 
1.8 cineole and Car-AuNPs and deduce whether or not they would induce similar effects in 
the same experimental conditions. 
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1.8 cineole inhibited cell viability in a dose dependent manner (Figure 3.16) in which the 20 
µl/ml concentration caused the greatest level of inhibition of cell viability. In all cases the 
means were statistically different from the control except for the 5 µl/ml concentration of the 
1.8 cineole. Conversely the 20 µl/ml of the 1.8 cineole showed highly significant levels of 
inhibition reducing cell viability by more than 50%. 
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3.2.3 Mitotic Index     
 
Mitotic index was quantified in order to determine the effects of 1.8 cineole and the AuNPs 
on the mitosis of CHO cells. Additionally, the assay was performed in order to determine 
whether the compound and AuNPs would induce similar effects when applied under the same 
experimental conditions. 
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Quantification of the effects of 1.8 cineole and AuNPs on mitosis is shown in Figure 3.17. 
The study showed that 1.8 cineole had an inhibitory effect on the MI of the cells after 24 h. 
The 5 µg/ml and 10 µg/ml Car-AuNPs stimulated mitosis (11 and 12% respectively). Both 
concentrations of 10 nm AuNPs stimulated the CHO cells to the same extent (8 and 9%) 
whereas 5 µg/ml of 50 nm AuNPs stimulated mitosis (10%) whilst 10 µg/ml 50 nm AuNPs 
induced a ~78% stimulation in mitosis. 5 µg/ml 5 nm AuNPs stimulated mitosis up to ~9% 
when compared to the 6 % of controls whereas the addition of 10 µg/ml of 5 nm AuNPs to 
cells had no effect on the MI of CHO cells. Both concentrations of Car-AuNPs applied to 
cells showed statistically significant (P<0.001) differences when compared to controls whilst 
statistically significant (P<0.05) were seen in cells exposed to 5 µg/ml of 50 nm AuNPs when 
compared to controls. The active compound of cardamom (1.8 cineole) statistically 
significantly reduced mitosis (P<0.01) after 24 hours. The effects of 5 nm and 10 nm at 
Figure 3.17: The effect of 1.8 cineole and AuNPs on mitotic index. 1) Control 2) 1.8 cineole (20 
µl/ml) 3) Car-AuNPs (5 µg/ml) 4) Car-AuNPs (10 µg/ml) 5) 5 nm AuNPs (5µg/ml) 6) 5 nm AuNPs 
(10µg/ml) 7) 10 nm AuNPs (5 µg/ml) 8) 10 nm AuNPs (10 µg/ml) 9) 50 nm AuNPs (5µg/ml) 10) 50 
nm AuNPs (10 µg/ml) 
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different concentrations were not statistically significant from those of the control and did not 
influence mitosis of the CHO cells. 
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3.3. Proton experiments 
 
3.3.1  Cell Survival 
 
The cellular radiosensitivity expressed as surviving fraction at 6 Gy was determined by the 
cell survival clonogenic assay. Cell survival data for the CHO cells are shown in Fig 3.18. 
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A visible reduction in the surviving fractions of cells can be seen when comparing the 
surviving fraction of CHO cells irradiated in the middle of the SOBP position compared to 
cells irradiated at the entrance plateau position in Figure 3.18. The addition of AuNPs to 
proton irradiation resulted in an even greater decrease in the surviving fractions of the cell 
populations in both positions compared to controls that were not treated with 50 nm AuNPs 
(p<0.001). These results show a clear dose enhancement effect of 50 nm AuNPs in CHO cells 
irradiated with 200 MeV protons. 
 
Figure 3.18: Surviving fractions of cells after the concurrent treatment of 6Gy protons in the 
entrance plateau and the middle of the SOBP (control) and a combined treatment of 6 Gy 
protons with 50 nm AuNPs (37 µM) at the same positions. Plating Efficiency (PE) of 0.82 for 
CHO cells treated with AuNPs without radiation was taken into account. 
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3.3.2 Chromosomal Damage 
 
Chromosomal damage in CHO cells treated with AuNPs and irradiated with protons was 
determined by using the micronucleus assay. Micronuclei provide a convenient and reliable 
index of both chromosome breakage and loss due to radiation damage. The CBMN assay was 
carried out in samples with the addition of Cyt-B leading to BN cell formation (see Figure 
3.19). The assay allows better precision analysis because the results cannot be confounded by 
cell division kinetics.  
For the CBMN experiments, CHO cells were exposed to 50 µg/ml of 5 nm AuNPs, 10 nm 
AuNPs and Car-AuNPs for 4 hours prior to irradiation with a 2 Gy dose of protons. For the 
experiments with 50 nm AuNPs cells were exposed to 10 µg/ml (37 µM) of 50 nm AuNPs 
for 4 and 24 hours prior to proton irradiation with 2 or 4 Gy doses. A low background 
number of MNi was observed in the control samples that were treated with different AuNP 
types (~12 MNi/500 BN cells) and not irradiated with protons. However, a noticeable 
increase in MNi could be seen when cells were exposed to protons, AuNPs with protons and 
with increasing proton dose (4 Gy). 
 
  
Figure 3.19 Images of BN cells containing A) no MNi B) two MNi C) one MNi and D) BN cell 
containing no MNi and a mononucleated cell in promethaphase of mitosis.  
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Figure 3.20 illustrates the number of MNi/500 BN cells after a 4 h incubation with 50µg/ml 
of 5 nm, 10 nm and Car-AuNPs followed by 2 Gy proton irradiation. The cells were 
irradiated at 3 different positions in the SOBP (see Figure 2.2). Statistically significant 
differences were seen in all cases comparing the MNi yield of samples exposed to AuNPs 
and protons compared to the MNi yields of samples exposed to protons alone (P<0.01). The 5 
nm and 10 nm AuNPs with protons showed significantly higher MNi yields when compared 
to irradiated controls at the same positions (proximal and middle positions of the SOBP). 
Car-AuNPs increased the number of MNi in the middle of the SOBP only (P<0.01). The MNi 
yields for CHO treated cells with 10 nm AuNPs and 2 Gy protons was 254 MNi/500 BN cells 
(P<0.05), 284 MNi/500 BN (P<0.01) and 273 MNi/500 BN cells compared to 187MNi/500 
BN cells 181 MNi/500 BN cells and 231 MNi/500 BN cells for CHO cells treated with 
protons alone at the proximal, middle and distal positions of the SOBP respectively. Car-
AuNPs influenced MNi expression minimally in the proximal and distal SOBP positions. 
Exposure of cells to 50 nm AuNPs for 4h and 2 Gy proton irradiation did not result in a 
pronounced dose enhancement effect (Figure 3.21). However, the incremental increase in 
MNi expressed with increasing depth along the SOBP was not clear in samples treated with 
50 nm AuNPs exposed to 2 Gy doses of proton radiation. A radiosensitization effect was 
observed in cells exposed to the combination of 4 Gy protons and AuNPs compared to its 
irradiated controls, but this was less clear for the middle of the SOBP position. From Figure 
3.21, it is suggested that a dose enhancement effect occurred in the entrance plateau with an 
increase of 431 MNi/500 BN to 519/500 BN cells and an increase from 300 MNi/500 BN 
cells to 450 MNi/500 at the proximal SOBP position. This effect disappeared with increasing 
depth.    
After treatment of CHO cells with 10 µg/ml of 50 nm AuNPs for 24 h a, decrease in MNi 
frequency was seen with the presence of 50 nm AuNPs and 2 Gy protons (160 MNi/500 BN 
cells) in the entrance plateau when compared to irradiated control values (207 MNi/500 BN 
cells). Whilst a significant increase MNi frequency is reflected in cells containing AuNPs 
irradiated in the middle of the SOBP when compared to controls.  
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3.3.3. Cell cycle kinetics 
 
Propidium iodide (PI) staining detected by flow cytometry was utilized to investigate the 
effects of proton radiation with and without AuNPs on cell cycle progression. Figure 3.23 
depicts the most pronounced effects on cell cycle kinetics caused by specific AuNPs alone 
and AuNPs with a 6 Gy dose of protons. All exposure scenarios can be found within the 
addendum. 
 
  
Figure 3.23: The effect of 10 nm (50 µg/ml) and 50 nm (10 µg/ml) AuNPs and a 6 Gy dose of 
protons on cell cycle progression (A and B)  depict negative controls for each condition, C) and 
D) show corresponding AuNP treated controls and E) and F) show the combined effect of AuNPs 
and 6 Gy protons.  
Both the 10 and 50 nm AUNPs depicted in figure 3.23 showed pronounced 
radiosensitization effects in the distal positions of the SOBP. Additionally both AuNPs 
induced a G0/G1 accumulation (increasing from 33.94% to 71.70% in the presence of 10 
nm AuNPs and from 33.27% to 42.26% in the presence of 50 nm AuNPs when compared 
to controls) without irradiation.  
 
E 
A 
C 
B 
F 
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Cell populations shifted towards G2M in an incremental manner with increasing depth along 
the SOBP when concurrently administered with protons as shown within the tables that 
follow. 
Table 3.3: The effect of Car-AuNPs and protons on cell cycle progression  
 
Car-AuNPs caused a 9% increase in the G0/G1 population and caused a 7% decrease in the 
G2/M population as shown in Table 3.3. The S phase cells remained unchanged. A similar 
effect is visible when assessing the irradiated conditions in the presence of AuNPs. 
Table 3.4: The effect of 5 nm AuNPs and protons on cell cycle progression  
Condition SOBP 
POSITION 
G0/G1 S G2/M 
Non-IR Control N/A 55.22% 9.17% 31.92% 
5 nm-AuNP Treated, 
Non-IR 
N/A 48.96% 11.83% 37.27% 
Irradiated Control Entrance Plateau 26.18% 20.66% 45.08% 
Proximal  23.74% 19.70% 45.16% 
Middle 22.03% 20.54% 48.03% 
Distal 22.20% 21.58% 45.94% 
5 nm-AuNP Treated, 
Irradiated 
Entrance Plateau 23.04% 20.09% 48.06% 
Proximal 22.51% 17.89% 49.15% 
Middle  24.59% 17.79% 47.18% 
Distal 21.03% 21.52% 48.78% 
 
5 nm AuNPs on their own influenced the cell cycle progression by causing an increase in 
G2/M population shown above in Table 3.4. In conjunction with 6Gy protons, minimal 
CONDITION SOBP 
POSITION 
G0/G1 S G2/M 
Non-Irradiated Control N/A 33.27% 40.88% 25.49% 
Car-AuNP Treated, 
Non-IR 
N/A 42.26% 39.39% 18.03% 
Control IR Entrance 
Plateau 
38.26% 16.63% 41.86% 
Car-AuNP treated, IR  Entrance 
Plateau 
49.95% 16.96% 32.20% 
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influences on all phases of the cell cycle were observed when compared to the irradiated 
controls. 
Table 3.5: The effect of 10 nm AuNPs and protons on cell cycle progression 
  
10 nm AuNPs caused an increase the cell fraction in the G1-phase (Table 3.5). Cells in G1 
increased from 33.94% to 71.70% seen in non-irradiated controls. When applied in 
combination with protons however, cells became more evenly distributed between G0/G1 and 
G2M and a large decrease in the fraction of cells in the S-phase could be seen across all 
conditions when compared to irradiated controls. Irradiated conditions compared to their 
internal reference control position revealed that the largest difference in cell phase 
populations is seen when comparing the distal position to the reference irradiated position. 
Additionally, the G2/M block induced at the irradiated control distal position is reduced by 
approximately 15% in the AuNP exposed condition whilst the G0/G1 increased by 25.76% 
and the S-phase population decreased.   
 
 
 
 
 
 
Condition SOBP Position G0/G1 S G2/M 
Non-Irradiated 
Control 
N/A 33.94% 37.63% 26.81% 
10 nm-AuNP 
treated, non-IR 
N/A 71.70% 8.12% 19.04% 
Irradiated Control 
Entrance Plateau 28.93% 11.48% 58.45% 
Proximal  28.54% 9.98% 60.29% 
Middle 28.48% 8.27% 61.25% 
Distal 13.66% 15.01% 68.98% 
10 nm-AuNP 
treated, Irradiated 
Entrance Plateau 37.72% 6.83% 54.30% 
Proximal 33.97% 10.00% 55.16% 
Middle  36.43% 9.19% 53.24% 
Distal 39.42% 7.33% 52.23% 
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Table 3.6: The effect of 50 nm AuNPs on cell cycle progression.  
 
An approximate 10% increase in the G0/G1 fraction can be seen in the presence of 50 nm 
AuNPs when compared to non-irradiated controls. This influenced the amount of cells in 
G2/M with a corresponding decrease of approximately 7%. Irradiation with protons, caused 
an incremental increase that correlates to depth in cell migration to G2/M in the controls. This 
resulted in decreases in G0/G1 populations sharing the most pronounced effect to be existed 
in the distal position of the SOBP with 60.25 % cells having migrated to G2/M. An 
anomalous decrease in the G2/M population is evident in G2/M population irradiated in the 
middle of the SOBP.  The combination of protons and AuNPs revealed decreases in G0/G1 
populations by approximately 10 % when compared to irradiated controls. This resulted in 
cell migrations into the S and G2/M phases resulting in slight increases in their respective 
populations when compared to irradiated controls. 
 
 
 
Condition SOBP POSITION G0/G1 S G2/M 
Non-Irradiated Control N/A 33.27% 40.88% 25.49% 
50 nm-AuNP Treated, 
Non-IR 
N/A 42.26% 39.39% 18.03% 
Irradiated Control Entrance Plateau 44.78% 14.87% 39.47% 
Proximal  27.21% 28.86% 43.14% 
Middle 45.74% 15.87% 39.23% 
Distal 20.28% 18.29% 60.25% 
50 nm-AuNP Treated, 
Irradiated 
Entrance Plateau 34.20% 28.91% 36.33% 
Proximal 36.70% 28.74% 34.06% 
Middle  31.29% 30.09% 38.17% 
Distal 17.64% 16.35% 64.88% 
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CHAPTER 4: DISCUSSION 
4.1 Introduction 
 
Radiation therapy (RT) is central to cancer treatment. About fifty percent of cancer patients 
receive radiotherapy as part of their treatment. Despite rapid technological advances, studies 
have reported high incidences of treatment related morbidity and side effects including 
secondary cancers, cardiovascular complications and fertility issues (Newhauser & Zhang, 
2015). It is thus imperative to explore other unconventional radiation therapy modalities that 
have the potential to improve radiotherapy outcomes along with the patient’s quality of life 
during treatment. The advantage that proton therapy (PT) could bring in sparing normal 
healthy tissue is an important evolution in modern radiation oncology (Valdivieso, et al., 
2012). 
Along with the rapid advancement of nanotechnology in recent years, the potential value of 
AuNPs as novel radiosensitizers has been discovered (Su, et al., 2014). For this study, the aim 
of incorporating AuNPs into radiation therapy is to increase its therapeutic efficacy while 
limiting damage to the surrounding cells. More specifically, the incorporation of AuNPs with 
the radiation is to improve the differential effect between tumours and healthy tissue (Retif, et 
al., 2015). 
The aim of this study was to explore the possible dose enhancement effect that AuNPs have 
on cells impacted with protons at clinically relevant energies (200 MeV beam of protons). 
Preliminary time and dose dependent effects of different sized AuNPs as well as AuNPs 
synthesized from cardamom that previously displayed radioprotective effects when exposed 
to X-rays, influenced the choice of AuNPs used in this study. Cells treated with different 
sized (5, 10 and 50 nm) AuNPs were irradiated as attached monolayers with 200 MeV 
protons at different depths along the SOBP in order to determine whether AuNPs could 
induce a depth-dependent radioenhancement effect in PT.  
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4.2 AuNP characterization 
 
4.2.1 UV-vis Spectroscopy 
 
UV-visible spectroscopy is widely used in the study of nanomaterials as a diagnostic of 
nanoparticle formation. UV-vis spectroscopy often provides a means of choice to gauge 
responses in analysis to changes applied to AuNP colloidal systems. It has been further 
suggested that the spectroscopic properties of nanoparticles can provide an indicator of their 
size distribution by fitting the position of their surface plasmon resonance (SPR). SPR occurs 
when AuNPs are excited by electromagnetic waves resulting in the support of coherent 
oscillations of conduction electrons at the surface of the AuNPs. Upon scattering, SPR 
coupled with these electromagnetic waves results in a depolarized speckle pattern whose 
fluctuations yield precise information on the AuNP size (Tanev, 2009).  
4.2.1.1 Car-AuNPs 
 
Adjusting multiple parameters in the synthesis procedure of Car-AuNPs revealed that the 
combination of optimal extract preparation and temperature played the greatest role in 
ensuring the production of Car-AuNPs with moderate size distributions that were stable in 
suspension. Optimal synthesis occurred at higher temperatures (75-85 °C). A change in 
AuNP suspension colour and the production of a more purple hue as opposed to a ruby red 
colour indicated AuNP agglomeration at lower temperatures (see Fig 5.1 of Addendum). 
Conversely, the deep purple colour was replaced by ruby red with increasing temperatures in 
a rapid 11 minute reaction. The change in colour was reflected in the absorptive intensity of 
the AuNPs, producing AuNPs with smaller λmax. The decrease in λmax values indicates a 
decrease in AuNP size (Figure 3.2). Corresponding findings were presented by Mountrichas 
et al.  It was revealed that higher temperatures speed up the reaction mechanics and that the 
produced nanoparticles were more uniform in size (Mounthricas, et al., 2014). Furthermore, 
an additional study by Tran et al, revealed that increasing the synthesis temperature of 
AuNPs resulted in smaller AuNPs and consequently smaller SPR bands. This corresponds to 
the findings depicted in Figure 3.2. In addition, the authors showed that even though 
reactional temperature played a role in the outcome of the NPs, the parameter with the 
greatest influence on AuNP quality was the amount of reducing and capping agents (Tran, et 
al., 2016). This effect was also observed in this study wherein cardamom extract served as the 
reducing and capping agent. 
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The same change in colour was observed when the extract was prepared differently by 
changing the parameters of the synthesis procedure (Figure 3.1A) as displayed by the 
absorbance profiles produced for each sample (Figure 3.3). The absorbance profile of the 
Car-AuNPs synthesized with whole cardamom seeds had a much longer SPR band (λmax: 
534 nm) than the Car-AuNPs synthesized with extract prepared from crushed cardamom 
seeds (λmax: 580 nm). The long SPR band exhibited, is a well-known sign of particle 
aggregation within solution and the accompanying purple colour of the solution allows visual 
affirmation of the agglomeration (Huang & El-Sayed, 2010). This difference in AuNP quality 
could suggest that extract quantity or, more specifically in this instance, the amount of 
phytochemicals present within the extract, directly affects NP size, shape and stability which 
in turn affects the quality of the NP. From the results depicted in Figure 3.1 A and Figure 3.3, 
it can be speculated that by crushing the cardamom seed a greater amount of biomolecules 
may have been freed into the extract solution resulting in a more efficient reduction of 
HAuCl4 and subsequent AuNP capping with phytochemicals. According to Sujitha and 
Kannan, 2013, at higher quantities of extract, nanoparticle synthesis is greatly favoured due 
to the availability of sufficient biomolecules that are responsible for capping and stabilizing 
AuNPs (Sujitha & Kannan, 2013). This finding is further supported by a study performed by 
Singh and Srivastava. Using an extract prepared from black cardamom, the authors varied the 
HAuCl4 to quantity of black tea extract applied in the synthesis procedures at ratios of 1:1, 
1:05 and 1:01 respectively. A gradual increase in the size of the AuNPs occurred when the 
amounts of extract was decreased (Singh & Srivastava, 2015). The increased size directly 
correlated to an increase in SPR band width. A similar phenomenon was seen in AuNPs 
synthesized using Phoenix dactylifera L. leaf extract. Varying the volume between 200-400 
µl of extract, the authors observed a shift in the SPR from 544-538 respectively, citing an 
increase in the number of AuNPs formed due to an increase in extract volume as the reason 
for the greater level of absorbance intensity (Zayed & Eisa, 2014).   
4.2.1.2 Citrate stabilized AuNPs 
 
The absorbance profiles of the 5, 10 and 50 nm AuNPs revealed λmax values of 540, 542 and 
536 nm respectively (Figure 3.4). According to the specifications by supplier Sigma Aldrich, 
the 5 nm and 10 nm AuNPs absorb at an optical density of 1 between wavelengths measuring 
510-525 nm. The increase in SPR band widths seen, could be due to the AuNPs losing a 
proportion of stability over time, causing some agglomeration and a longer SPR band. 
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However, the AuNPs absorbed light within the characteristic wavelength of AuNPs and 
exhibited ruby red colours that varied in shade (Figure 1.1 B) due to AuNP size. Thus it could 
be deduced that the AuNPs were relatively stable and acceptable for in vitro use. The same 
statement could be made for the 50 nm AuNPs, however no agglomeration was evident and 
the absorbance of the 50 nm AuNPs was within the range outlined by Sigma Aldrich (535-
539 nm) indicating appropriate levels of stability. 
4.3 Dynamic Light Scattering (DLS) and Zeta Potential 
 
4.3.1. Car-AuNPs 
 
Crushing the cardamom seeds prior to synthesis clearly yielded a more favourable colloidal 
solution with the resultant colour comparing positively to that of the citrate stabilized AuNPs 
(Figure.1.1 A and C). Whole cardamom seeds yielded AuNPs that were considerably 
polydisperse (PDI: ±0.4), and prone to aggregation made clear by the colour of the AuNP 
solution. The AuNPs synthesized from extracts of crushed cardamom seeds differ from the 
whole Car-AuNPs both in size, shape and dispersity. Crushed seed extract yielded AuNPs 
that were monodisperse (PDI: ±0.2). In both cases however, there was a discrepancy between 
the sizes with DLS and those measured with TEM (Table 3.1). This discrepancy is possibly 
due to organic molecules that are absorbed or chemisorbed onto the surface of the AuNP in 
suspension (Salata, 2004). This suggests that additional phytochemical solvent layers are 
present containing biomolecules with varying molecular weights causing the greater size 
measured when compared to TEM (approximately 11 nm in diameter) and the commercial 
AuNPs. According to Green and Hersam, 2010, the extreme variability in composition and 
concentration in different plant extracts present a challenge, making it difficult to establish 
tightly controlled, reproducible synthesis protocols (Green & Hersam, 2010). With that being 
said, the Car-AuNPs produced in this project appear to be superior to the Car-AuNPs initially 
produced by Pattanayak et al in 2013, their final AuNPs were double the size 
(hydrodynamically measured: 423.3 nm) of those created in this project (Pattanayak, et al., 
2013). It is probable that the specific adapted extract preparation that was used in this study 
together with the temperature controlled synthesis caused the improvement in AuNP quality. 
4.3.2 Commercial (Citrate Stabilized) AuNPs 
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The sizes of AuNPs are measured with TEM, which is used as an estimate of the core size of 
AuNPs. DLS measures the core of the AuNPs within suspension, however, hydrodynamic 
light scattering layers surrounding the AuNPs result in larger sizes than what is recorded by 
other methods. (Abbai, et al., 2016). According to Coradeghini et al, it is normal to observe a 
difference in particle size made in a vacuum by electron microscope than those made in 
solution using DLS, since the physical parameter measured is fundamentally different. Using 
5 nm and 15 nm citrate stabilized AuNPs, Coradeghini et al revealed that DLS measurements 
yielded sizes that were 4.5 and 5 nm greater in size than AuNPs measured by STEM 
respectively. Both the measured 10 nm and 50 nm AuNPs sizes, were greater than the core 
sizes recorded by electron microscopy (Table 3.1). Both measured an additional 23 nm (33.47 
d.nm) and 15 nm (65.64 d.nm) respectively. The sizes remained relatively confined (to core 
sizes and DLS measurements outlined by suppliers) and the presence of single peaks for each 
AuNP, referred to moderate size distributions as confirmed by the polydispersity indices of 
the AuNPs (0.2 and 0.1). Based on this data, it could be concluded that the AuNPs were 
stable and monodisperse. Supplementary to the DLS measurements, the charge of the AuNPs 
were -32.8 mV and -35.1mV respectively. The AuNPs are considered anionic and stable as 
the charges of the AuNPs comply with the standard values of AuNP charge as outlined 
above.   
The 5 nm AuNPs, however, showed an unexpected increase in size (176.4 nm). The result 
suggested a level of agglomeration in the AuNPs which was made evident by the multiple 
peaks present (Figure. 3.5 A). Additionally, a high PDI of ±0.4, indicated that the distribution 
of the NPs within solution was imbalanced and that agglomerates detected as large AuNPs 
existed within solution. Analysis of the percentage of AuNPs falling within certain size 
ranges however, revealed that the greater proportion of AuNPs in solution measured 15 nm 
whereas the minor proportion measured above 1000 nm which affected the average diameter 
recorded. The major proportion of AuNPs falling within the appropriate size range still 
served as confirmation of the correct AuNP size. The zeta potential (-44.1 mV) of the 5nm 
AuNPs indicated that the solution was relatively stable along with the wine red colour (Figure 
1.1 B) of the 5 nm AuNP solution. In order to resolve the problem of agglomeration, the 
AuNPs were all filtered prior to experimentation. Filtering AuNPs prior to treatment served 
an additional purpose of alleviating the polydispersity seen within the AuNPs. We believe 
that by filtering the AuNPs through 0.2 µm filters, a narrower size distribution is achieved 
due to the agglomerates becoming trapped within the filter (see Figure 5.4 of the Addendum). 
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4.4 TEM, EDS and SAED 
  
Transmission electron microscopy is a commonly used imaging technique which allows the 
visualization of multiple substances at a high resolution. It provides the true (core) size of an 
AuNP. The Car-AuNP size and shape was visually confirmed by TEM. The images revealed 
morphological variability (spherical, triangular, rod-shaped, cuboid and hexagonal) among 
the AuNPs synthesized with whole cardamom seeds (Figure 3.7 B and D) whilst the AuNPs 
synthesized with crushed cardamom were uniformly spherical (Figure 3.7 A and C). Levels 
of agglomeration were also present in both samples but to greater levels within the AuNPs 
synthesized from the whole cardamom seeds. At greater resolutions (2 nm), the crystalline 
nature of the AuNPs were revealed by the lateral fringes demarcating the AuNPs from its 
centre to its edge (Figure 3.7 E and F). Furthermore, elemental analysis (Figure 3.8 A and B) 
showed that the NPs consisted of gold (the Copper (Cu) and Carbon (C) present within the 
EDS spectra is due to the grid (coated with Cu and C on each surface respectively) on which 
the AuNP samples were placed for imaging)). The intense bright spots on the speckle pattern 
of SAED (Figure 3.9) showed that the NPs were indeed crystalline corresponding to the 
lateral fringes seen within the TEM images and thus served as final confirmation of 
successful AuNP synthesis. Similar results could be seen in a study by Sujitha & Kannan, 
2013 wherein morphological variability in AuNP shapes produced by green synthesis was 
exhibited with TEM (Sujitha & Kannan, 2013). According to Sujitha & Kannan, 2013, blunt 
angled nanotriangles are a result of the shrinking process arising from the minimization of 
surface energy. The presence of large extract quantities cause strong interactions between 
protective biomolecules and surfaces of nanoparticles preventing nascent nanocrystals from 
sintering. Increasing the quantities of extract, increases the interaction, leading to size 
reduction of nanoparticles and sphere formation (Sujitha & Kannan, 2013). Additionally, the 
authors confirmed AuNP crystallinity and fcc structure by SAED analysis corresponding to 
the findings of this study. 
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4.5 Stability testing  
An important aspect of nanoparticle characterization is measurement under conditions that 
resemble a physiological in vitro environment. One of the important parameters is the 
stability and the level of aggregation of AuNPs in different media commonly used with 
biological assays (Pavlin & Bregar, 2012). Therefore, stability tests were performed wherein 
AuNPs were exposed to increasingly complex biological media for 24 hours at 25 and 37 o C. 
The addition of AuNPs to biological media resulted in an immediate change in their spectra. 
However, with the exception of the spectral curves for PBS (due to particle aggregation 
occurring upon the addition of salt containing buffers) (Sharma, et al., 2015) (Figure 3.10 A-
D), the AuNPs maintained their spectra when compared to the spectral curves of AuNPs 
without the addition of media (Figure 3.2-3.4.). This stability disappeared with certain 
conditions after a 24 hour incubation with the 5 nm, 10 nm and 50 nm AuNPs whilst the Car-
AuNPs retained a level of stability (Figure 3.11 A-D).  
A multitude of factors may have contributed to the findings obtained, however the most 
likely factor is the specific synthesis method. The 5, 10 and 50 nm AuNPs had previously 
been synthesized commercially and stabilized by capping with citrate. These AuNPs 
remained in storage at 4 o C until required whereas the Car-AuNPs were synthesized when 
needed. Thus, the difference in the storage time frame between the green AuNPs and 
chemically synthesized AuNPs may have affected the difference in stability over time prior to 
stability testing. The second factor for consideration is the citrate coating of the AuNPs. 
According to Sharma et al, citrate as a capping agent weakly associates with the NP surface 
and is readily displaced by a range of other molecules including amines, thiols, polymers, 
proteins and antibodies (Sharma, et al., 2015). As soon as the particle comes into contact with 
heterogenous environments, liquid or gaseous, smaller structures attach to the surface of the 
particle. This surface is known as the corona in biological environments where biomolecules 
are present (Elsaesser & Vyvyan Howard, 2012).  According to the findings of Chegel et al, 
these organic molecules contain both thiol and amine groups that both strongly promote NP 
aggregation (Chegel, et al., 2012).  
Closer assessment of the incubation conditions revealed that the greatest level of 
agglomeration occurred at 37 o C within media and supplemented media. This could be due to 
the activation of serum proteins at 37 o C within the culture media, usually present to cater to 
the cells cultured in it. In this case, the increased activation of these proteins may have 
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resulted in greater protein corona development resulting in higher levels of AuNP 
aggregation. According to Elbagory et al, the flattening of SPR is due to the formation of 
larger particles. The stability levels of Car-AuNPs are also substantiated by the findings of 
their study wherein green AuNPs synthesized from different extracts exhibited excellent 
stability after 24 hours (Elbagory, et al., 2016). 
4.6 AuNP uptake 
 
ICP-MS was performed in order to determine whether AuNPs had successfully been taken up 
into the cells. Concentrations of 2.5 µg/ml, 5 µg/ml and 10 µg/ml of 10 nm and 50 nm 
AuNPs were applied to the cells for 24 hours and their uptake measured after the respective 
incubation period. The quantities yielded in parts per billion (ppb) were converted in order to 
obtain the amount of AuNP uptake per cell as well as the total quantity in µg/ml (Table 3.2). 
The uptake of AuNPs by the cells was influenced by the concentration of the AuNPs used. 
More gold was detected in cells exposed to higher concentrations of AuNPs. The greatest 
level of uptake was exhibited by the 10 nm AuNPs (Figure 3.12). Approximately 92%, 90% 
and 84 % of the 10 nm AuNPs were taken up after exposure to concentrations of 2.5 µg/ml, 5 
µg/ml and 10 µg/ml respectively whereas ~72% of all the concentrations applied of the 50 
nm AuNPs were effectively, internalised by the cells. These findings contradict a multitude 
of studies wherein comparisons between AuNPs of different sizes were assessed for their 
uptake capabilities. A study by Chitrani et al, using ICP-AES, revealed that the larger AuNPs 
(50 nm spherical AuNPs) were taken up more efficiently than smaller AuNPs (14 nm) and 
larger AuNPs (74 nm) (Chitrani, et al., 2010). Additionally, different types of NPs (50 nm in 
size) have been shown to exhibit highly efficient endocytosis capabilities which is 
conjectured to be due to similar vesicle sizes required at the initial cellular stage of entry for 
several viruses (Osaki , et al., 2004; Chitrani, et al., 2010; Chu, et al., 2011). 
Endocytosis is the major route of NP transport across the membrane and is generally 
classified into phagocytosis and pinocytosis. Four subclasses of pinocytosis are present in all 
cell types namely, clathrin-dependent endocytosis, caveolae-dependent endocytosis, 
micropinocytosis and clathrin-and-caveolae independent endocytosis based on the proteins 
involved in the pathways (Hillaireau & Couvreur, 2009). NPs are generally considered to 
enter the cells via either of these pinocytic pathways however, it has been described that there 
are differences in how nanomedicines interact with the cytomembrane. Different types of 
NPs enter cells and travel into the cells via different routes (Kou, et al., 2013). However, 
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some pathways are still insufficiently understood and factors affecting the pathway of 
nanomedicines entering the cells are not absolutely proven (Sahay, et al., 2010). Although a 
trend in size dependent endocytic mechanisms exists, additional factors may contribute to 
AuNP uptake other than size. According to Sahay et al, most studies performed so far do not 
emphasize the link between cell origin and various endocytic pathways. Furthermore, the 
known cellular pathways may be differentially expressed or even totally absent in selected 
cell types depending on cell phenotype (Sahay, et al., 2010). Self-regulated membrane 
tension by cells are usually small. However, with increasing NP size, wrapping the NP would 
put the membrane in increasingly high tension (Zhang, et al., 2015). Thus an upper limit of 
NP radius exists beyond which endocytosis does not occur. This tension could also be a 
contributing factor to consider as various studies revealed decreasing cellular uptake with 
larger AuNPs. Therefore, the possibility exists that a difference in cell type may cause an 
alteration in membrane tension resulting in lowered tolerance of larger AuNPs and could be a 
contributing factor towards the discrepancy in uptake effect seen here when compared to 
literature (Osaki , et al., 2004; Chitrani, et al., 2010; Chu, et al., 2011). 
4.7  In vitro assessments 
 
The mitotic index (MI) (Figure 3.17) indicated that the active compound of cardamom (1.8 
cineole) greatly inhibited the capacity of the cells to divide whilst Car-AuNPs stimulated the 
division of the cells when compared to controls. 1.8 cineole has been found to inhibit cell 
growth (Murata, et al., 2013). In this study, 1.8 cineole also exhibited an outspoken inhibitory 
effect on cell viability and thus cell growth. Based on work by Rajan, et al, Car-AuNPs were 
shown to inhibit cell growth (Rajan, et al., 2017). According to Diaz et al, the inhibitory and 
sometimes toxic effects of the Car-AuNPs nanoparticles is highly dependent on the type of 
cell encountered. This is due to variations in cell physiology, proliferation state, membrane 
characteristics and phagocyte characteristics among different cell types (Díaz, et al., 2008). 
This statement is further supported by the findings of Patra et al, who explored non 
functionalized AuNPs in multiple in vitro models. Whilst the AuNPs managed to induce 
death responses in the lung cancer cells, no effect was seen in hamster kidney cells nor liver 
cancer cells (Patra, et al., 2007). Another possible explanation is that green synthesized 
AuNPs possess several more solvent layers than the AuNPs synthesized via chemical 
synthesis procedures (Salata, 2004). Thus, even though 1.8 cineole was found to drive the 
synthesis reaction of Car-AuNPs (Singh & Srivastava, 2015), it is possible that 1.8 cineole 
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does not form part of the proportion of phytochemicals surrounding the AuNPs. In a study by 
Nune et al, a number of phytochemicals present in black tea were considered the major role 
players in the overall reduction reactions of HAuCl4. Via a systematic investigation of their 
individual roles, the authors found that the cocktail of phytochemicals present in the tea acted 
synergistically in stabilizing the AuNPs (Nune , et al., 2009). It can therefore be speculated 
that the AuNPs stemming from the cardamom aqueous extract were created by a chemical 
reaction that was driven by 1.8 cineole. However, there is a likelihood that the 
phytochemicals existing in addition to 1.8 cineole within the bulk phytochemical complex, 
were responsible for capping the AuNPs, resulting in phytochemicals with stimulatory 
capacities covering the AuNP surface. 
Stimulation of mitosis exhibited by Car-AuNPs could also be seen in cells exposed to the 
5nm, 10nm and 50 nm AuNPs (Figure 3.17). However, the level of stimulation was minimal 
when compared to Car-AuNPs. Additionally, doubling the concentration of citrate stabilized 
AuNPs (10 µg/ml), either had no effect on mitosis or decreased the level of cell division 
stimulation. The effect was dose and size-dependent. The higher (10 µg/ml) concentration of 
AuNPs, decreased the mitotic index and 5 nm AuNPs at 5 µg/ml caused a minimal increase 
(from 6% in controls to 8.5% in the 5nm treated sample) in mitosis but no effect at the higher 
concentration (10 µg/ml). Both concentrations of the 10 nm and 50 nm (5 and 10 µg/ml) 
AuNPs had no significant effects on mitosis of the CHO cells (Figure 3.17). Although, the 
effect of the commercial AuNPs on mitotic index contrasts what is exhibited in the cell 
proliferation experiment however, it is important to note that the cell proliferation experiment 
occurred under high concentrations of AuNPs (50 µg/ml) (Figure 3.13). Thus, it is plausible 
that the stimulatory effect on mitosis shown in Figure 3.17 is lost with increasing 
concentrations of citrate stabilized AuNPs. Although of the commercial AuNPs, the 50 nm 
AuNPs caused the greatest stimulatory effect (from 6 % seen in control to approximately 9% 
exhibited in the treated sample) on the mitosis of the cells; its influence on the proliferative 
capacities of the CHO cells at higher concentrations did not affect cell proliferation in the 
same cytotoxic manner as the smaller AuNPs and had no effect on cell proliferation at lower 
concentrations after 24 hours (Figure 3.15). 
Similarity does exist in the cell proliferation and mitosis experiments, in that the Car-AuNPs 
stimulates cell propagation in both cases and to greater extents at increasing concentrations. 
Furthermore, The 5 nm and 10 nm AuNPs affect cell proliferation and mitosis similarly in 
that the 5 nm induced the greatest response (both inhibitory and stimulatory) whilst the 10 nm 
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AuNPs took on a more modulatory role. Simply put, the responses induced, though different, 
was similar in magnitude in both assays per exposure (AuNP type) condition. Similar results 
on the invasive capacities of cells and AuNP size were observed by Liu et al. In a lung cancer 
model, the authors found that 5 nm AuNPs inhibited the growth of A549 cells but increased 
cell invasion. Corresponding increases in cell invasion was exhibited by cells exposed to 10 
nm AuNPs, but no influence on viability or invasion could be seen in cells exposed to larger 
AuNPs (20 and 40 nm). These results suggest that the increased level of reactivity exhibited 
by smaller AuNPs relative to the larger AuNPs could be due to their increased surface area 
resulting in a greater AuNP to cell interaction. Additionally, the study by Liu et al, shows that 
AuNPs can induce variable stimulatory and inhibitory effects in vitro when applied in 
different assays corresponding to the findings of the current study (Liu, et al., 2014). 
4.8 Radiation Damage 
4.8.1  The Clonogenic cell survival assay 
 
To evaluate the radiosensitization effects of 50 nm AuNPs, the cell survival clonogenic assay 
was conducted to assess the self-renewal efficiency of CHO-K1 cells after exposure to the 
abovementioned treatments (see Figure 3.18).  
Decreases in colony formation were observed when comparing the reference radiation 
position to the middle of the SOBP, pointing to a gradual decrease in cell survival and thus an 
increase in biological effectiveness with depth. There was a reduction in surviving fractions 
from 0.082 in the entrance plateau position to 0.059 in the middle position of the SOBP. The 
presence of the AuNPs resulted in an even greater decrease in cell survival from 0.021 at the 
entrance plateau to 0.013 in the middle of the SOBP.  
Compared to the cell survival fractions observed for proton radiation alone, a clear dose 
enhancement effect of 74.4% for the entrance plateau positions and 78% for the middle 
position of the SOBP is visible. In a study by Ma et al, AuNPs of different shapes (gold 
nanospheres (GNPs), gold nanospikes (GNS), and gold nanorods (GNR) of similar sizes 
(average size ~50 nm each) were investigated as potential radiosensitizers (Ma, et al., 2017). 
After an incubation period of 24 h with the AuNPs, cellular uptake was revealed to increase 
in order of GNP>GNS>GNR. Based on gold mass, the GNPs showed the highest level of 
uptake. Additionally, employing the colony forming assay, the study revealed that 
radiosensitization with 6 MV X-rays (4Gy) were most pronounced in the presence of GNPs 
and sensitization enhancement ratios (SER) proved that the AuNPs enhanced radiation 
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therapy. The ratios calculated were 1.62, 1.37 and 1.21 respectively, corresponding to the 
level of cellular uptake of the GNPs. The AuNPs used in this study were also 50 nm spherical 
AuNPs and based on the colony survival data for 6 Gy protons, an increase of approximately 
75% in effectiveness could be observed for AuNP treated cells compared to untreated cells 
(Figure 3.18). 
Polf et al 2011, investigated the enhancement of cell death and RBE based on the presence of 
AuNPs in prostate cancer cells upon proton radiation. The research group exposed DU145 
cells containing phage-scaffold AuNPs with a diameter of 44 ± 8 nm (internalizing phage 
plus gold nanoparticles) to 160 MeV protons. Reference data was produced by exposing non-
treated cells to the same incremental doses of clinical 60 Co photons to determine the baseline 
sensitivity of DU145 cells to the reference radiation quality. Using the standard in vitro 
clonogenic assay, the findings of the study revealed that DU145 cells are more sensitive to 
proton irradiation and the AuNP treated cells showed an even further decrease in cell 
survival, representing an approximate 15-20% dose enhancement for Au treated cells. The 
authors attributed the effect to proton-Au scatter interactions that increase the ionization 
density within cells (Polf, et al., 2011). The dose enhancement effect reported by Polf et al, 
was smaller than the effect observed in the current study, however, there are differences in 
the experimental conditions and both studies showed the reduction in cell survival due to 
increasing ionization events upon AuNP-proton interaction. 
Unfortunately, limited data is currently available on the depth-dependent increase in the 
radiosensitization effect of AuNPs for proton irradiation. Li et al, .observed an enhanced cell 
death with increasing LET of the proton radiation (Li, et al., 2016). However, this group 
worked with a 2 MV Tandem accelerator, resulting in protons of a very low energy and hence 
a higher biological effectiveness than the higher energy protons used in clinical practice. A 
human epidermoid carcinoma cell line (A431) was treated with 5 nm and 10 nm AuNPs and 
irradiated with protons of 25 keV/μm and 10 keV/μm. A marked radiosensitization effect was 
observed for the high LET protons, but not with the 10 keV/μm protons. Furthermore, the 
effect was more pronounced for 10 nm AuNPs than for 5 nm AuNPs. In our study, however, 
the LET of the protons at the entrance plateau position corresponded to 3.39 keV/μm for the 
entrance plateau position and 3.624 keV/μm for the SOBP position (unpublished data, 
Vandevoorde, 2017). 
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4.8.2 Chromosomal Damage 
 
The cytokinesis block micronucleus assay was used to determine the amount of radiation 
damage induced after exposing the cells to AuNPs and protons by using micronuclei as a 
biomarker for chromosomal damage. 
The assessment of MNi yields in cells after pre-incubation with AuNPs after each individual 
incubation period in cells, and subsequent irradiation with protons revealed that the AuNPs 
do interact with protons. An increase in micronuclei frequency could be seen in cells exposed 
to 5 or 10 nm AuNPs (50 µg/ml) and protons compared to cells treated with protons or 
AuNPs alone.  At all depths along the SOBP, the observed dose enhancement effects were 
different when compared to irradiated controls. However, when compared amongst each 
other, the middle of the SOBP showed a statistically significant difference between the 5 and 
10 nm AuNP treated cells namely, 251MNi/500 BN cells and 286MNi/500 BN cells 
respectively. This finding is consistent with results reported by Li et al, wherein the A431 
cell line was pre-incubated with 5 or 10 nm AuNPs and subsequently treated with 10 and 25 
keV µm protons. As previously reported, a more pronounced effect was observed in cells 
incubated with 10 nm AuNPs compared to 5 nm AuNPs. This outcome could be partially 
attributed to AuNP uptake. Due to the greater of size of the AuNPs, a greater AuNP mass is 
present within cells, increasing the probability of interaction with protons and AuNPs. Thus 
an increased enhancement is expected for AuNPs that are slightly larger due to an increased 
gold atom presence within the cells with which the protons can interact (Li , et al., 2016). 
Therefore, the size dependent effect seen (10 nm producing more chromosomal damage) in 
Figure 3.20 could be dependent on an increase in gold mass within the cells. 
 
In contrast to the result obtained with the commercial AuNPs, cells pre-incubated with ± 11 
nm Car-AuNPs showed a decrease in MNi expression in response to protons except for the 
position in the middle of the SOBP (see Figure 3.20). Both the proximal and distal position in 
the SOBP yielded interaction indices (Unity) lower than 1 (0.94 and 0.72 respectively) 
(addendum), pointing to a radioprotective effect, which might be due to the previously 
described stimulation of proliferation in CHO cells. This protective effect seen could also be 
credited to the biological species within the phytochemical complex. For low-LET radiation 
1/3 of DNA damage occurs via direct damage whilst 2/3 of DNA damage occurs due to 
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indirect damage (Azzam, et al., 2012). As previously described in section 1.4 of Chapter 1, 
indirect damage produces a multitude of DNA lesions by producing free radicals. By free 
radical scavenging and upregulating endogenous enzymes capable of neutralizing free radical 
induced cellular damage, phytochemical constituents can effectively infer radioprotective 
capabilities onto cells (Paul, et al., 2011). In a study by Dhuley, rats fed with high fat diets 
and cardamom were monitored for antioxidant enzyme activity. The study showed a marked 
enhancement of antioxidant enzyme activity proving that an antioxidant protection effect 
appeared to occur due to a cardamom supplemented diet in rats (Dhuley, 1999). In addition to 
the bulk monoterpenes found in cardamom (section 1.3.2, chapter 1), a large reservoir of 
polyphenols (e.g flavonoids) exists within the phytochemical complex of cardamom 
(Daneshi-Maskooni, et al., 2017). Polyphenols are competent reactive oxygen species 
scavengers. Finally, as previously described in section 1.3.2 of chapter 1, it has been proven 
that Car-AuNPs are effective reactive oxygen species scavengers (Soshnikova, et al., 2017). 
Thus the radioprotecting effect seen with the Car-AuNPs could also be ascribed to the 
presence of polyphenols capping the AuNPs as solvent layers. 
An interaction between 50 nm AuNPs and protons was also visible (Figure 3.21). As seen 
within the experiment mentioned above, a greater level of micronuclei frequency was seen in 
cells exposed to 50 nm AuNPs and protons when compared to cells exposed to 50 nm AuNPs 
or protons alone. Pronounced effects could be seen at all positions of the SOBP in cells 
exposed to 50 nm AuNPs and 2 Gy protons. Statistically significant differences existed 
between the MNi induced when the cells were irradiated at the different SOBP positions and 
their controls as well as the 80% Dmax position. However, no statistically significant 
differences existed between MNi at different positions (expect the middle of the SOBP which 
is due to an uncharacteristic decline in micronuclei frequency within the irradiated controls). 
This radiosensitizing effect was also reflected in the dose enhancement factors seen at these 
positions with the distal portion of the SOBP in particular, producing a Unity of 1.2 (Figure 
5.6 of Addendum). This effect is also present at higher doses (4 Gy), and after a longer pre-
incubation period (24 hours) with 50 nm AuNPs (Figure 3.22). For the irradiated controls, we 
observe an increase in MNi frequency with depth along the proton beam as shown in both 
Figure 3.21 and 3.22. This is somewhat expected, as a great amount of studies has determined 
an incremental increase in RBE to be seen with increasing depth. This is a direct consequence 
of an increase in ionization density with greater depths along the proton beam due to a 
decrease in proton energy (Michaelidesová, et al., 2017).  
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However, this increase in induced radiation damage with depth was not observed in cells 
treated with AuNPs where the dose enhancement remained more or less the same for each 
position. This can be explained by a simulation performed by Lin et al, in which the Monte 
Carlo simulations predicted interactions of a single 50 nm AuNP particle with 10 MeV and 
150 MeV protons (Lin, et al., 2014). Their results presented similarities to the findings of this 
study. The simulation anticipated that protons would interact with 50 nm AuNPs and that a 
DEF up to 14 times greater than normal proton irradiation could be seen. Additionally, 
AuNPs enhanced the dose of administered protons independently of the position along the 
peak and with greater efficiencies at 10 MeV than 150 MeV energies (Lin, et al., 2014). This 
finding could explain the effects seen in Figure 3.21. Per position, a randomized increase in 
micronuclei frequency was seen with dose enhancement being lost at the 80 % Dmax position 
when compared to the distal position of the SOBP. This loss of enhancement could be 
attributed to a steep increases in ionization energies in distal regions of the beam resulting in 
decreased dose enhancement capabilities by AuNPs. The minimal increase in MNi frequency 
when compared to non-treated controls at higher doses (4 Gy) on the other hand, could in fact 
be a direct result of increased dose. 
Another factor to consider is AuNP size. Findings by Chitrani et al, showed that 50 nm 
AuNPs exhibited greater uptake efficiencies when compared to smaller AuNPs. Additionally, 
radiosentization was seen to greater extents with photons with 50 nm AuNPs when compared 
to AuNPs that were larger and smaller than 50 nm AuNPs (Chitrani, et al., 2010). However, 
when comparing the dose enhancements of the 10 nm AuNPs (Figure 3.20) to that of the 50 
nm AuNPs (Figure 3.21) in the current study, a greater level of enhancement is seen with the 
smaller AuNPs. This is in agreement with the ICP-MS results, which indicated a higher 
uptake of 10 nm AuNPs compared to 50 m AuNPs (Table 3.2), which may have been 
responsible for a larger dose enhancement effect.  According to Li et al, due to the greater 
surface area of AuNPs with decreasing size, the “hit probability” of protons with AuNPs is 
vastly improved (Li , et al., 2016).  
Due to the large number of electrons in atoms with high atomic numbers, such as gold, many 
electrons can be released in Auger cascades in addition to the primary ionization process. 
Radiosensitization with AuNPs is largely attributed to this Auger effect when working with 
keV X-rays, hence a Monte Carlo simulation by Lechtman et al, explored radiosensitization 
due to Auger electron emission as a function of AuNP size. The authors found that three 
distinct zones could be identified in the surrounding media from AuNP radiosensitization 
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upon interaction with photons. The first, comprised about 3-32% of the total escaping energy 
and extends about 2 µm from the AuNP surface due to escaping Auger and photon electrons. 
Subsequently this zone has an increased RBE due to the increased LET of these particles. As 
a consequence, the radioenhancement due to AuNPs is largely caused by the energy deposits 
of this zone. The limiting factor for the use of larger AuNPs however, is that they tend to 
internally absorb the short range low energy electrons due to their high stopping power for 
low energy electrons, reducing the relative energy contributions of the Auger electrons 
(Lechtman, et al., 2011). The dominant process of proton interactions with gold is the 
production of secondary electrons via small angle scattering. While photon-induced 
ionizations occur homogenously in the medium, the situation is drastically different for 
proton radiation. Considering fluences typically employed in proton therapy and the small 
diameter of AuNPs, the direct traversal of a proton through a NP is much less probable 
(Walzlein, et al., 2014). Contrasting the inner-shell ionizations seen in photon-gold 
interactions, these events commonly lead to the ejection of low energy electrons from outer 
atomic orbitals. It was revealed that Auger electrons contribute only 1.5 % of AuNP mediated 
dose and that of the variety of radiation modalities, clinically used energies produce 
secondary electrons of the lowest energies when compared to those produced by other types 
of irradiation (Lin, et al., 2014). Thus, the decrease in Auger electron production by protons 
and its possible absorbance by 50 nm AuNPs could explain the decrease in MNi expression 
depicted in Figure 3.21. Even though the AuNPs did enhance the effect of the applied proton 
doses on the cells, the enhancement seen was not as pronounced as the level of dose 
enhancement caused by the 10 nm AuNPs in Figure 3.21. An additional factor to consider 
however, is AuNP quantity. As mentioned above, it is likely that the sensitization effect 
caused by the 10 nm AuNPs could be due to an increased gold mass within cells. In addition, 
ICP-MS results showed a better cellular uptake of the 10 nm AuNPs compared to the 50 nm 
AuNPs. 
After exposing the cells to the 50 nm AuNPs for 24 hours (Figure 3.22), the same level of 
dose enhancement was exhibited when compared to the proton interaction with cells pre-
incubated with 50 nm AuNPs for 4 hours. The increase in exposure time of CHO cells to 
AuNPs may have caused the minimal increase in dose enhancement effect exhibited. The 
estimated doubling time of CHO cells is 15 hours, thus, within the 24 hour incubation period 
the CHO underwent mitosis resulting in the division of endocytosed AuNPs between 
daughter cells causing a decreased quantity of AuNPs within individual cells though 
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increased AuNP uptake could have occurred due to the increased incubation period (Kim, et 
al., 2012). It is also important to note the enhancement effect caused by the 50 nm AuNPs 
was induced via an applied concentration that was 5 times lower than the concentration of the 
10 nm AuNPs applied to the cells. According to Lechtman et al, the applied concentration of 
AuNPs to the cell is another important parameter governing optimal AuNP-irradiation 
interaction (Lechtman, et al., 2011). Thus it is plausible, that an increase in 50 nm AuNP 
concentrations to a quantity that does not distort the media: AuNP ratio in vitro could lead to 
greater levels of radiation damage due to an increased presence of AuNPs directly correlating 
to increased gold mass within cells. 
It is unfortunately not possible to evaluate which size of the AuNP has the greatest dose 
enhancement capability, since the CHO cells were exposed to different concentrations of 5 or 
10 nm (50 µg/ml) and 50 nm (10 µg/ml) for 4 hours. Future experiments are needed with 
similar concentrations of AuNPs and similar incubation times to investigate this further.  
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4.8.3 Cell cycle kinetics  
 
Flow cytometry is a technique that is able to make multiple, objective, simultaneous 
measurements at the single-cell level at the rate of several events per second (Wilson & 
Marples, 2007). Flow cytometry incorporating the PI staining method was used to assess the 
effect of AuNPs, protons and the combination of AuNPs and protons on cell cycle 
progression.  
CHO-K1 cells were exposed to 4 different exposure scenarios that involved Car-AuNPs and 
protons (50 µg/ml), 5 nm AuNPs (50µg/ml), 10 nm AuNPs (50 µg/ml) and 50 nm AuNPs (10 
µg/ml). These were all pre-incubated within cells for 4 hours prior to irradiation with 6 Gy 
protons.  
4.8.3.1 Car-AuNPs 
 
Car-AuNPs proved to have a minimal effect on the cell cycle when compared to controls 
(Table 3.3). Car-AuNPs stimulated cell growth (Figures 3.13 and 3.17) so no changes in cell 
cycle progression would be observed in these samples. Car-AuNPs exhibits no disruptive 
activity to cellular mechanics resulting in unperturbed cell cycle progression. The addition of 
protons however, revealed that the cell populations in G2/M decreased in favour of a 10 % 
increase of the cell population in G0/G1. The S-phase remained relatively unchanged. Also 
known as the growth and longest phase of the cell cycle, G0/G1 occurs with the aid of 
stimulation by growth factors. Thus, the stimulatory mechanism previously exhibited by Car-
AuNPs may have played the same stimulatory role on the cell cycle of the CHO-K1 cells 
resulting in a longer G0/G1 and decreased G2/M. The shorter G2/M may also be due to the 
radioprotective mechanism of Car-AuNPs previously described resulting in Car-AuNPs 
desensitizing the cells to radiation causing a shorter G2/M. This was also made evident by a 
decrease in RCGG from 2.52 (Table 5.8 of Addendum) for irradiated controls to 1.90 for 
irradiated samples with Car-AuNPs.  
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4.8.3.2 5 nm AuNPs 
  
The 5 nm AuNPs showed some effect on cell cycle progression when compared to its non-
irradiated control. A decrease in the G0/G1 population from 55.22% to 48.96% (Table 3.4) 
with an increase in the G2/M population from 31.92% to 37.27% occurred whilst the changes 
to the S-phase population was minimal. The modest effect seen on cells could be due in part, 
to the uptake efficiency of the AuNPs. Uptake efficiencies measured by using the mean side 
scatter of the control and treated samples to produce a ratio (Roa, et al., 2009), revealed that 
the 5 nm AuNPs showed the least amount of endocytosis (0.82) when compared to its other 
AuNP counterparts (Fig of 5.2 of the Addendum). It has already been established in previous 
sections that in order to see similar effects to the larger AuNPs, greater amounts of smaller 
sized AuNPs need to be applied in order to observe any significant effects due to the smaller 
AuNPs resulting in less gold mass presence within the cells. However, this finding 
contradicts the work of Liu et al, wherein 5 nm AuNPs arrest the cell cycle within the G0/G1 
phase of the cell cycle (Liu, et al., 2014). However, the NPs applied by Liu et al had a longer 
incubation period (24 hours) with 50 µg/ml of AuNPs which could account for the difference 
in effect seen. When assessing the response to radiation on the cell cycle, similar minimal 
changes to the cell cycle kinetics could be seen. This could be attributed to the decreased 
amounts of AuNPs resulting in less interaction with protons. The effect seen does not 
correspond to the radioenhancement effect exhibited by the 5 nm AuNPs in the CBMN assay 
(Figure 3.20), thus further investigation is required to validate this result.  
4.8.3.3 10 nm AuNPs 
 
The 10 nm AuNPs induced a substantial G1/G0 block when compared to non-irradiated 
controls. An increase from 33.94% -71.70% (Table 3.5) occurred with subsequent decreases 
in the S-phase and G2/M populations. As previously described in section 1.6.4.1., G1 arrest 
occurs in response to genotoxic damage. Arrest can occur by either upregulating p53 or 
degrading Cdc25A with the ultimate goal of downregulating Cdk2 in order to repress kinase 
activity of D cyclins resulting in the eventual G1 arrest. It is likely that the presence of the 10 
nm AuNPs within CHOs influenced the expression of these molecules resulting in G1 arrest. 
In response to proton radiation, the majority of the cells accumulated in G2/M for all positions 
along the SOBP. When comparing the AuNP irradiated samples to these controls, a decrease 
in the G2/M population is visible. The S-phase populations remains relatively unchanged 
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whilst increases in G1/G0 populations are evident and most pronounced towards the end of 
the SOBP. One of two events may have occurred which explains the given effect. Either A) 
the effect seen is due to G0/G1 taking on an intermediate position towards radiation 
sensitivity resulting in cells being re-distributed amongst G0/G1 and G2/M or B) the stall seen 
without radiation in response to 10 nm AuNP presence at G0/G1, persists during radiation, 
thus a radiosensitizing mechanism may exist. The decline in cell populations stalled in G0/G1 
from 71.70% (10nm AuNP non-IR) to 39. 42% (10 nm IR) in G1 (distal SOBP position) and 
an increase in the accumulation of cells in G2/M (52.23%) when compared to the G2M 
populations of the 10 nm non-irradiated control (19.04%). This is further substantiated by the 
RCGG of the irradiated control in the distal position increasing from 4.60-7.13 (Table 5.2 of 
Addendum) with the addition of AuNPs. These findings contradict the findings of Liu et al, 
wherein no effect could be seen on the cell cycle kinetics of lung cancer cells with 10 AuNPs 
alone (Liu, et al., 2014). Additionally the findings of Geng et al are also contradicted wherein 
~14 nm glucose capped AuNPs created a G2/M stall on their own (without radiation) and 
enhanced the delivered dose of 90kVp and 6 MV X-rays by further increasing the cell 
populations stalled in G2/M of SKOV3 cells. This difference in effect is most likely due to 
the different cell models used across these investigations in relation to ours (Geng, et al., 
2011). Furthermore, the AuNPs used in this study were not modified with biomolecules and 
thus the additional physicochemical parameters that may play a role in the study by Geng et 
al do not factor into the findings of this study. However, the variety in effects reported 
combined with those from this study warrants further investigation. 
4.8.3.4 50 nm AuNPs 
 
The 50 nm AuNPs showed decreased G2/M expression (from 25.49 % to 18.03%), increased 
G0/G1 expression from (33.27% to 42.26%) and similar S-phase expression (from 40.88% to 
39.39%) when compared to controls (Table 3.5). However, proton irradiation resulted in a 
decrease in S-phase accumulation and subsequent increases in G2/M cell populations, 
particularly for the distal SOBP position. Similar effects were observed in cells exposed to 50 
nm AuNPs and protons. The increase in G2/M population when compared to irradiated 
controls was minimal. The latter suggests that the 50 nm AuNPs did not affect the 
radiosensitivity of the cells. Smaller RCGG values and even smaller differences between the 
values 3.92 and 3.29 (Table 5.11 of the Addendum) when comparing the distal position 
control to the irradiated AuNP treated sample, confirms the minimal influence on 
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radiosensitization. This finding is similar to those yielded by the micronucleus data described 
in section 4.8.2. However it contradicts the findings of Chitrani et al wherein 50 nm AuNPs 
(7 × 109 nanoparticles/ml) were found to exhibit the greatest uptake efficiency and 
radiosensitization effect in response to X-ray radiation (Chitrani, et al., 2010). Another study 
by Ma et al, 2017, revealed that ~ 50 nm AuNPs (50 µg/ml) had arrested cells in the G2/M 
phase of the cell cycle possibly sensitizing the cells to X-ray irradiation (Ma, et al., 2017). 
The lack in correspondence of these studies to the findings of this study could also be due to a 
different incubation periods. In the study by Chitrani et al Hela cells were exposed to AuNPs 
for up to 72 hours whilst the report by Ma et al, indicated a 24 hour exposure time frame. 
Findings by Kim et al, 2012 revealed that within 10 hours of incubation AuNP uptake did not 
affect the phases of the cell cycle (Kim, et al., 2012). As the study showed that the 50 nm 
AuNPs were not endocytosed as efficiently as 10 nm AuNPs and that minimal effects were 
seen on cells containing 50 nm AuNPs and protons after a pre-incubation period of 4 hours 
(Figure 3.12), the allocated time (4h) for effective AuNP endocytosis may have been too 
short resulting in the minimal effect on cell cycle kinetics exhibited by the 50 nm AuNPs. 
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SUMMARY  
 
In this study, the differential effects induced by AuNPs synthesized using green methods and 
chemical methods were explored. AuNPs were then administered in conjunction with protons 
at clinical energies (200 MeV) in order to determine whether an enhancement in radiation 
effects could be seen due to AuNP presence within the cells. 
Initial non-irradiative experiments revealed that chemically synthesized AuNPs induced 
variable effects in vitro. Decreases in cell proliferation were seen in cells exposed to 5 and 10 
nm AuNPs whilst increased mitotic indices were expressed due to 5 and 10nm AuNPs. The 
50 nm AuNPs showed little effect on cell proliferation whilst stimulation of mitosis was 
observed. This result, though variable indicated a size dependent effect of the commercial 
AuNPs. In contrast, results from both the cell proliferation and mitosis experiments showed 
that Car-AuNPs clearly stimulated cell growth leading to increased mitotic index readings 
along with corresponding increases in cell proliferation. 
Incorporating AuNPs with proton radiation revealed that an interaction between protons and 
AuNPs exists. Results observed from the cell survival clonogenic assay showed a marked 
AuNP induced dose enhancement effect of approximately 75 % when compared to irradiated 
controls. Data from the chromosomal damage assessments revealed that with the exception of 
the middle of the SOBP, protons influenced the level of expressed MNi in a depth dependent 
manner. However, this depth dependent increase in MNi induction was not reflected in the 
data yielded from cells treated with protons and AuNPs. Furthermore, the effect of AuNP size 
contradicted the findings stated in literature. Data obtained from ICP-MS and chromosomal 
damage experiments revealed that the 10 nm AuNPs were internalised more efficiently and 
exhibited the most pronounced radioenhancement effect compared to the expected theory that 
this would be exhibited in cells exposed to 50 nm AuNPs. In addition, the radioprotective 
mechanism exhibited by Car-AuNPs in response to protons requires further investigation. 
The core size of the Car-AuNPs is similar to the 10 nm AuNPs (in size), yet exerted a 
completely opposite effect. This led to the suspicion that the biogenic molecules forming part 
of the corona of Car-AuNPs (Nune , et al., 2009) may have played a radioprotective role by 
scavenging DNA damaging reactive oxygen species. 
Analysis of the effect of the aforementioned treatments on the cell cycle kinetics revealed that 
the radioprotecting mechanism of the Car-AuNPs persisted throughout different experiments. 
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On their own, Car-AuNPs affected the cell cycle minimally. Variable effects on the cell cycle 
were induced by the citrate stabilized AuNPs.  The 5 nm AuNPs caused minimal effects with 
and without protons on cell cycle kinetics whilst 10 nm AuNPs caused cells to accumulate in 
G0/G1.  
The findings of this study allowed for the following to be deduced; 
1. AuNPs exert variable effects on cell proliferation, division and cell cycle kinetics that 
are largely dependent on AuNP size 
2. AuNPs and protons do interact however the interaction does not occur in the depth-
dependent manner expected 
3. Different synthesis procedures can be associated with a differing capacity to modulate 
proton effects.  
4. AuNP concentration plays a central role in AuNP-proton interaction presumably 
affecting the “ hit probability” between protons and AuNPs 
5. Though the protons on their own affected the cells in a depth dependent manner, an 
anomalous decrease in cell damage and effect at the middle of the SOBP occurs and 
persists throughout the data set. There is no apparent biophysical explanation for this 
occurrence.  However, the fact that it was consistently observed as part of 
chromosomal damage and cell cycle kinetics warrants further investigation to 
illuminate an underlying mechanism. 
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CONCLUSION 
 
Stereotatic radiosurgery is a valuable tool as an alternative to surgery for a variety of benign 
intercranial meningiomas due to the selection of doses that causes total destruction. 
Conceived to create functional lesions within physiological tracts or nuclei of the brain, 
stereotactic radiosurgery has been used to treat meningiomas, acoustic neuromas and 
arteriovenous malformations. Due to increases in the size of the target volume or its 
proximity to critical structures, clinicians are increasingly using treatment schedules 
consisting of more than one fraction (Vernimmen & Slabbert, 2010). However, large lesions 
are more difficult to treat with radiosurgery. Proton beam therapy, with its dose distribution 
advantage offers an alternative radiation therapy option (Vernimmen, et al., 2005). The 
interaction of AuNPs and protons in this study is a significant step towards the improvement 
in the treatment of carcinomas. The dose enhancement capabilities of the AuNPs with protons 
at clinically relevant energies, with the addition of site targeted radiotherapy due to the 
conformal delivered dose of protons means that there is huge potential for AuNP application 
as a radiosensitizer in proton therapy.  
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CHAPTER 5: ADDENDUM 
 
5.1 AuNP images 
 
 
Figure 5.1: Photographic images depicting the difference in colour of AuNPs synthesized with 
different temperatures. A) AuNPs synthesized at 55 o C and RT B) AuNP synthesized at 55 o C and 
85 o C. 
5.2 UV-spectral curves 
 
 
 
 
 
 
B 
Figure 5.2: Temperature dependent synthesis of Car-AuNPs with extract prepared from whole 
cardamom seeds. 
Flat regions in lieu of defined SPR peaks indicate particle agglomeration and instability. The 
flattened SPR seen opposes the effect exhibited in Car-AuNPs synthesized from crushed seed 
extract. 
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Figure 5.3:  The effect of HAuCl4 quantity on AuNP quality. A) AuNP synthesized as described in 
section 2.1.3.1. B) AuNP synthesis 200µl HAuCL4 instead of 300 µl. 
Reduction of HAuCl4 quantity resulted in longer SPR bands indicated increased AuNP size. 
The SPR bandwidth increased from a ʎmax of 538 to ʎmax of 548 
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5.3 DLS and Zeta Potential 
 
 
 
Figure 5.4: Size distribution curves prior to and after filtering the AuNPs. The size of the AuNPs 
were largely reduced and the proportion of AuNPs present within the second peak reduced from 3.6% 
to 0.6%. Additionally the first peak proved a narrower size distribution of AuNPS with 99.4% of 
AuNPs falling within the lower size range depicted. The large AuNP read could simply be an artifact 
or debris. 
 
Table 5.1: The stability of Car-AuNPs over time.  Car-AuNP stability in storage was measured by 
Zeta Potential and DLS over time. 
Time of characterization DLS Zeta Potential PDI 
Same day as synthesis 262.6 d.nm -17.4 mV 0.247 
2 weeks post synthesis 262 d.nm -19.7 mV 0.258 
4 weeks post synthesis 256 d.nm -17.5 mV 0.211 
A 
B 
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5.4 AuNP uptake 
 
Table 5.2 AuNP uptake efficiency determined using mean side scatter obtained from flow cytometry  
 
Sample Non-IR Mean SSC 
Uptake 
efficiency 
Control 1 014 808,38   
Car-AuNP 1 272 961,06 1,25 
Control 1 349 196,07   
 5 nm AuNP 1 110 363,04 0,82 
Control 1 409 500,86   
10 nm AuNP 1 803 518,81 1,28 
Control 1 416 769,18   
50 nm AuNP 1 417 853,31 1,00 
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5.5 Statistical analysis of Mitotic index 
 
  
Figure 5.5:  Analysis of Variance and Student Newman Keuls 
data showing the cumulative p value of the data set (p<0.001) 
and statistically significant differences between all means. 
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5.6 Reference data of CSA 
 
Table 5.3.: The cell survival clonogenic assay performed with two concentrations of 10 AuNPs after 
a 24 hour pre-incubation period. 
Incubation with AuNPs at low concentrations for 24 hours and a subsequent 6 day growth 
period revealed that colony formation was minimally affected by the presence of AuNPs in 
vitro as indicated by the resultant plating efficiencies (PE). 
 
Table 5.4: The cell survival clonogenic assay performed with two concentrations of 10 nm AuNPs 
and 8 Gy of C60 radiation. 
 
Establishing PEs for cells treated with AuNPs allowed for the approximation of dilution 
routes required to obtain appropriate cell quantities for proton experiments. 
 
 
 
 
 
 
 
 
 
Sample # Cells plated # Colonies 
counted 
Mean % PE 
Control 200 179,170,168,169 171 85 
10 µg/ml AuNP  200 190,203,204,180 194 97 
5 µg/ml AuNP 200 256,278,244,247 256 128 
Sample # Cells plated # Colonies 
counted 
Mean % PE Surviving 
fractions 
Control IR 10 000 168,175,170,186 174 1.74 0.01 
10 µg/ml 
AuNP  
10 000 179,186,174,212 187 1.87 0.01 
5 µg/ml AuNP 10 000 191,160,175,181 176 1.76 0.01 
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5.7 Data distribution curves for chromosomal damage analysis 
 
 
 
 
 
 
Figure 5.7:  Distribution curves for MNi data of 50 nm AuNPs. 
Normal Prob. Plot; Raw Residuals
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Figure 5.6: Distribution curves for MNi data of 5, 10 and Car-AuNPs. Despite a few outliers, 
the data was relatively normally distributed 
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Figure 5.8: Distribution data of the MNi assay performed after a 24 hour incubation period with 50 
nm AuNPs.  The MNi data was normally distributed. 
5.8 Dose enhancement values (MNi) 
 
Table 5.5. Calculated DEFs for CHO cells treated with 5nm, 10nm and Car-AuNPs for 4 hours 
followed by proton radiation. 
 
SOBP condition Dose Unity 
5 nm AuNP Entrance SOBP 2 0,725543 
5 nm AuNP  Middle SOBP 2 1,273187 
5 nm AuNP Distal SOBP 2 1,049664 
10 nm AuNP Entrance SOBP 2 1,205371 
10 nm AuNP middle SOBP 2 1,395122 
10 nm AuNP Distal SOBP 2 1,067797 
Car-AUNP Entrance SOBP 2 0,945634 
Car-AUNP   Middle SOBP 2 1,293245 
Car-AUNP  Distal SOBP 2 0,728745 
 
 
 
 
 
 
 
Normal Prob. Plot; Raw Residuals
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Table 5.6 Dose enhancement values expressed after a 4 h incubation period of AuNPs and treatment 
with protons (2 Gy and 4 Gy) 
 
 
 
 
 
 
 
 
Table 5.7: Dose enhancement values expressed after a 24 hour incubation period of 50 nm AuNPs 
and treatment with protons 
SOBP position Dose Unity 
AuNP Entrance SOBP 2 0,730594 
AuNP Proximal SOBP 2 0,98254 
AuNP Middle SOBP 2 1,124046 
 
 
 
  
SOBP position condition Dose Unity 
AuNP Entrance Reference 2 1,038226 
AuNP Proximal SOBP 2 1,223473 
AuNP Middle SOBP 2 1,015355 
AuNP Distal SOBP 2 1,12069 
AuNP 80 % Dmax 2 1,027879 
AuNP Entrance Reference 4 1,173193 
AuNP Proximal SOBP 4 1,442308 
AuNP Middle SOBP 4 0,881412 
AuNP 80 % Dmax 4 0,953923 
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5.9 RCGG values (cell cycle kinetics) 
 
Table 5.8: RCGG values determined for Car-AuNP exposed cells 
Sample % S-phase % G2/M phase RCGG 
Control Non-IR 17,94% 31,16% 1,74 
Control Entrance Plateau 16,63% 41,86% 2,52 
Car-AuNP Non-IR 15,55% 29,43% 1,89 
Car-AuNP Plateau 16,96% 32,20% 1,90 
 
Table 5.9: RCGG values determined for cells exposed to 5 nm AuNPs, protons, and 5 nm AuNPs in 
combination with protons 
Sample % S-phase % G2/M phase RCGG 
Control Non-IR 9,17% 31,92% 3,48 
Control Entrance Plateau 26,18% 20,66% 0,79 
Control Proximal 23,74% 19,70% 0,83 
Control Middle 22,03% 20,54% 0,93 
Control Distal 22,20% 21,58% 0,97 
5 nm Non-IR 48,96% 37,27% 0,76 
5 nm Entrance Plateau 23,04% 20,09% 0,87 
5 nm Proximal 22,51% 49,15% 2,18 
5 nm Middle 24,59% 47,18% 1,92 
5 nm Distal 21,03% 48,78% 2,32 
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Table 5.10: RCGG values determined for cells exposed to 10 nm AuNPs, protons and 10 nm AuNPs 
in combination with protons 
Sample % S-phase % G2/M phase RCGG 
Control Non-IR 37,63% 26,81% 0,71 
Control Entrance Plateau 11,48% 58,45% 5,09 
Control Proximal 9,98% 60,29% 6,04 
Control Middle 8,27% 61,25% 7,41 
Control Distal 15,01% 68,98% 4,60 
10 nm Non-IR 8,12% 19,04% 2,34 
10 nm Entrance 
Reference 
6,83% 54,30% 
7,95 
10 nm Proximal 10,00% 55,16% 5,52 
10 nm Middle 9,19% 53,24% 5,79 
10 nm Distal 7,33% 52,23% 7,13 
 
Table 5.11: RCGG values calculated for cells exposed to 50 nm AuNPs, protons and 50 nm AuNPs in 
combination with protons 
Sample % S-phase % G2/M phase RCGG 
Control Non-IR 40,88% 25,49% 0,62 
Control Entrance Plateau 14,87% 39,47% 2,65 
Control Proximal 28,86% 43,14% 1,49 
Control Middle 15,87% 39,23% 2,47 
Control Distal 18,29% 60,25% 3,29 
50 nm Non-IR 39,39% 18,03% 0,46 
50 nm Entrance 
Reference 28,91% 36,33% 1,26 
50 nm Proximal 28,74% 34,06% 1,19 
50 nm Middle 30,09% 38,17% 1,27 
50 nm Distal 16,35% 64,88% 3,97 
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5.10 Cell cycle kinetics 
  
Figure 5.9: Non-irradiated controls of CHO cells. Negative controls are depicted on the left whilst 
sample B) contains 50 ug/ml of 5 nm AuNPs D) contains 50 ug/ml of 10 nm and F) contains 10 ug/ml 
of 50 nm AuNP images on subsequent pages depict these conditions with the addition of 6 Gy of 
protons at different positions along the proton beam. 
A B 
C D 
E F 
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Figure 5.10: The effect of Car-AUNPs on cell cycle kinetics. Non-Irradiated controls are depicted in A) 
and B) whilst irradiated samples in the entrance plateau with and without Car-AuNPs are depicted in C) 
and D). 
A B 
C D 
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Figure 5.11: The effect of 5 nm AuNPs on cell cycle kinetics. Irradiated controls are depicted on the left, 
whilst irradiated samples containing AuNPs are shown on the left. Samples in row A) and B) are 
irradiated in the entrance plateau position, C) and D) the proximal, E) and F) the middle G) and H) the 
distal positions of the SOBP. 
G 
F E 
C D 
B A 
H 
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Figure 5.12: The effect of 10 nm AuNPs on cell cycle kinetics. Figures on the right, depict irradiated 
controls without gold, whilst figures on the right depict irradiated samples without gold. 
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Figure 5.13: The effect of 50 nm AuNPs on cell cycle kinetics. Irradiated controls are depicted on the left, 
whilst irradiated samples containing AuNPs are shown on the left. Samples in A) and B) are irradiated in 
the entrance plateau position, C) and D) the proximal, E) and F) the middle G) and H) the distal positions 
of the SOBP. 
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